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ABSTRACT

Perillyl alcohol and perillic acid enhanced the sensitivity of head and neck cancer
cells to radiation treatment in vitro
by
Daniel Samaila
Dr. J. Abiodun Elegbede, Examination Committee Chair/Adviser
Assistant Professor o f Biochemistry
University o f Nevada, Las Vegas

Limonene and perillyl alcohol are the naturally occurring monoterpenes found
commonly in plant fruits and vegetables. Perillyl alcohol (POH) elicited anticarcinogenic
effects in a number o f caneer models and pharmacokinetie studies in humans revealed
that perillie acid (PA) is the major eireulating metabolite following POH administration.
Effects o f these monoterpenes eombined with and without radiation on human head and
neck squamous cell carcinoma cell lines (HNSCC) were measured using eytotoxicity and
flow eytometry assays. HNSCC cells were pretreated with 1.0 mM PA or 0.5mM POH
for 72 hr before exposure to IG y or 2Gy radiation dose. Pretreatment with l.OmM PA or
0.5mM POH sensitized the eells to radiation, causing growth inhibition in HTB-43 (50%
and 71%), SCC-25 (55% and 68%) and BroTo (18% and 53%) cells, respectively. PA
induced cell-cycle arrest in G q/G i phase, caused cell death via apoptosis and a reduction
in p53 protein in SCC-25 eells.
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CHAPTER 1

INTRODUCTION
1.1

Purpose o f the study

The rate o f occurrence o f head and neck squamous cell carcinomas (HNSCC)
“account for about 13,000 o f all cancer deaths” in the United States (Cancer Facts and
Figures 2004). Currently, combination therapy, drug treatments followed by radiation
elicit higher survival rates and more effective in preserving of organs in the body than
other cancer treatment (Kies et al., 2001; Yokes et al., 2003). This treatment option cure
rate is higher than the cure rate for the well known traditional method o f treating head
and neck cancer using surgery with radiation therapy. Treatment o f local and regional
head and neck squamous cell carcinoma, in combination with therapy using drugs like
fluorouracil, paclitaxel and hydroxyurea with radiation control local and regional head
and neck cancer better than either radiation alone or drugs (Kies et al., 2001; Yokes et al.,
2003). Though chemo-radiotherapy showed a better cure rates for treating this type o f
cancer with increased survival than other forms o f therapy, the drugs commonly tested
were toxic to the body causing low level o f white blood cells (i.e. leucopenia and
thrombocytopenia) (Kies et al., 2001; Yokes et al., 2003). Therefore, there is need to
develop new agents that will be less toxic to the body and increase survival rates (Kies et
al., 2001; Yokes et al., 2003).
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The naturally occurring plant monoterpenes are constituents o f many fruits and
vegetables commonly consumed by humans namely, oranges, spearmint, cherries and
others (Alonso et al., 1992; Kjonaas and Croteau, 1983). The monoterpenes, limonene
and perillyl alcohol (POH), were reported to elicit anticarcinogenic effects in a number
o f animal smdies (Elegbede et al., 1984, 1986, and1993) and are currently undergoing
clinical trials in the US and Britain (Ripple et al., 2000; Murren et al., 2002; Chow et al.,
2002). Pharmacokinetic studies o f POH in humans revealed that the major eireulating
metabolite is perillic acid (PA) (Ripple et al., 1998; Ripple et al., 2000; Murren et al.,
2002; Chow et al., 2002). This implies that PA may be involved in the meehanism o f
action o f POH. The goal o f this research is to investigate if PA will sensitize head and
neck cancer eells to radiation effeets when used in eombination ehemo-radiation
treatment in vitro.

1.2

Research questions

The mechanism o f action o f the monoterpenes has not been fully established, it has
been reported that monoterpenes are involved in regulation o f some cellular activities in
cell growth, including the up-regulation o f mannose-6-phosphate/insulin-like growth
factor II receptors (Jirtle et al., 1993), increased tissue growth factor receptors (Jirtle et
al., 1993) and the inhibition o f prénylation o f small GTP-binding proteins (Crowell et al.,
1991; Kawata et al., 1994). Other reported activities include the induction o f phase I and
phase II detoxification enzymes (Elegbede et al., 2002), expression o f Bak and
programmed cell death via apoptosis (Stayrook et al., 1997). This research work will
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elucidate the possible mechanism o f action o f PA as a radio-sensitizer o f HNSCC cells in
culture. This work will attempt to answer some o f the following research questions;
i)

Will PA sensitize head and neck cancer cells to radiation in chemo-radiation
treatment?

ii)

Will PA cause cell cycle arrest?

iii)

Will the radio-sensitization effect o f PA be due to cell death via apoptosis?

iv)

Will PA affect the expression o f p53 protein levels?

1.3

Significance o f the study

For many years research has been done on the risk factors associated with cancer and
on factors possibly associated with the prevention o f caneer development. The
identification o f possible agents commonly found in the food we eat that may be helpful
in preventing cancers shows great promise (Hakim et al., 2000). Progress in HNSCC
treatments has involved combination therapies that include naturally occurring substances
in foods. Treatment o f HNSCC using drug alone was reported to minimally increase the
response rate. However, due to low rates o f survival and high levels o f toxicity with the
common chemotherapeutic drugs and low cure rates with traditional methods (Landis et
al., 1998), efforts have been redirected at the use o f drugs that are less toxic in
combination with radiation to produce better cure rates (Rajesh et al., 2003). Synthetic
drugs SUCH AS fluorouracil, hydroxyurea or paclitaxel are generally very toxic which
underlies the necessity for developing newer agents that are less toxic for chemoradiotherapy (Yokes et al., 2003). Since monoterpenes are found naturally in plants
commonly consumed by humans, are less toxic to the body they have the potential to
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serve as radio-sensitizers in the combination chemo-radiation treatment o f HNSCC cells
in vitro. Since there is no information in the treatment o f HNSCC using PA in
combination with radiation, this research will broaden our knowledge regarding the effect
o f PA as a new agent with less toxicity in the treatment o f HNSCC in chemo-radiation
treatment in vitro and possible mechanism o f inhibition.

1.4 Hypothesis
Since PA is found to be the major circulating plasma metabolite in humans after the
administration o f POH, we therefore hypothesized that PA may be affecting cancer cell
cycles, thereby sensitizing the cells to irradiation effect. To test this hypothesis, we
proposed to investigate and confirm that pretreatment o f head and neck cancer cells with
PA will sensitize the cells to radiation effects.
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CHAPTER 2

LITERATURE REVIEW
Another group o f plant compounds that received attention as chemopreventive agents
in caneer therapies are the monoterpenes. Monoterpenes are naturally occurring
nonnutritive plant compounds that are synthesized via the mevalonate pathway in plants
(Chayet et al., 1977). These compounds function physiologically in plants as
chemorepellents and chemoattractants against insects and exhibit distinctive fragrances
observed in many plants (as reviewed by McGarvey and Croteau 1995). d-limonene
(Fig. I, p.7), the parent monoterpene synthesized through the mevalonate pathway serves
as the precursor for the synthesis o f other oxygenated monoterpenes including perillyl
alcohol, POH (Fig.I, p.7), menthol, perillyladehyde, and carveol (as review by McGarvey
and Croteau 1995). D-limonene and POH are the two naturally occurring monoterpenes
(Fig.l, p.7) found in the essential oils o f citrus fruits as well as caraway, lavender,
spearmint and cherries (Alonso et al., 1992; Kjonaas and Croteau, 1983).
Food commonly consumed by humans contains a large variety o f compounds that
either serve as blocking or suppressing agents in the inhibition o f tumors in the body
(Wattenberg, 1983 and 1985). These are often plant compounds (carotenes, phenols,
methylated flavones and plant sterols) which may either have preventive or blocking
activity against cancer. One o f the earliest studies o f this kind was reported by
Wattenberg (1983). Wattenberg studied the blocking effects o f some green coffee beans
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compounds on neoplasia. One basic role o f blocking agents is the ability to induce phase
I and phase II detoxification enzymes in the liver that prevent toxicity and tumor
development. Induction o f glutathione S-transferase activity is being used as a measure
for determination o f blocking effect o f kahweol palmitate and cafesol palmitate isolated
in the green coffee beans. W attenberg's group used rats induced with the chemical
carcinogen 7,12-dimethylbenz(a)anthracene and found that kahweol palmitate and
eafesol palmitate obtained from theses coffee beans inereased the aetivity o f glutathione
S-transferase which led to inhibition o f mammary neoplasia (Wattenberg, 1983).
Monoterpenes effects on human skin squamous cell earcinomas have been recently
studied. Hakim et al. (2000) condueted a cohort study in an Arizona population
commonly known for growing and consuming fresh citrus fruits. They compared the
history o f squamous cell earcinoma o f the skin and citrus consumption in the population
using a questionnaire for assessment o f eitms consumption prepared with citrus pulp and
peels supplemented as food among the participants. The predominant types o f citrus
prepared in this cohort study were grapefruits, orange and orange juice with grapefruit
having the highest percentage. Based on their findings there was no positive
“association” between eitrus consumption and squamous cell carcinoma o f the skin in the
subjects (Hakim et al., 2000). However, the level o f citrus peel intake and SCC was
found to be significant due to the high concentration o f limonene found in citrus peel
compared with other citrus content which has low concentration o f d-limonene (Hakim et
al., 2000).
In rat, Crowell (1992) reported the systematic availability o f the metabolites perillic
acid (PA) and dihydroperillic acid, (DHPA) (Fig.l, p.7) after administration o f d-
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limonene. Further study was done in vitro on the inhibition effect o f PA, on a murine
fibroblast cell line (NIH3T3). Rats were fed Ig limonene per kg body weight in com
oil. The rats were sacrificed through ether inhalation while blood and tissue samples
were collected for analyses o f limonene, PA and DHPA. The levels o f limonene, PA and
DHPA were detected using gas chromatography at low concentrations in samples
collected after 1 hr o f feeding, i.e., in lung (0.48pmol/g), semm (0.62pmol/g) and in
kidney (1.09pmol/g). In contrast, higher concentrations were found in adipose
(2.14pmol/g) and mammary gland tissues (l.lOpm ol/g) (Crowell et al., 1992).
Comparison o f the effects o f limonene or PA on cell proliferation o f murine fibroblast
cells showed that PA is more effective than limonene after 4 days exposures while
limonene minimally inhibited the viability o f cells while 3 mM PA caused complete
inhibition o f cell growth (Crowell et al., 1992).

O

OH

(-)-Limonene

(-)-Perillyl alcohol

(-)-Perillic acid

OH

Dihydroperillic acid

Figure 1 Stmctures o f the monoterpenes.
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2.2 Chemopreventive activities o f monoterpenes
Monoterpenes have been reported to possess either blocking or suppressing effects
against many different cancer models. In 1994, using orange peel oil containing about
90-95% d-limonene, Crowell et al used fasting men and women (23-55 yr) and were
asked to refrain from taking citrus fruits or soft drinks for a period o f 48 hr. Each person
was givenlOOmg per kg d-limonene in a semisolid custard-like food containing 5%
orange. Blood was then drawn from each subject before and twice ingestion after 4 and
24 h. The level o f toxicity o f the plasma metabolites was monitored in all participants
using capillary gas chromatography. After 4 hr post-ingestion the level o f PA (35pM)
was predominant, followed by DHPA (33pM) and limonene-2-ol (16pM) after 4 hr post
ingestion (Crowell et al., 1994b). No intrasubject change in d-limonene and metabolites
was observed in samples analyzed after the intake o f limonene but four out o f the seven
participants suffered from mild eructation while others reported mild satiety and slight
fatigue (Crowell et al., 1994b).
In 1984, Elegbede et al. determined the effects o f d-limonene in rats fed for a week
before induction o f tumor by DMB A. W hen rats were treated with limonene for one
week and subsequently treated with DMBA for a period o f 27 weeks it caused a decrease
in mammary tumor development compared to the control groups (Elegbede et al., 1984).
Elegbede et al. (1986) studied the effects o f orange oil and d-limonene in mouse skin
tumors in two-stage skin carcinogenesis induced by 7, 12-dimethylbenza[a]-anthracene
(DMBA) given in 0.2 ml o f acetone. The control group received 0.2 ml acetone while
the orange oil and d-limonene were administered topically or by dietary intake. Testing
started on the 7* day and lasted for another one-week period in which the tropically
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tested mice were treated with 12-0-tetradecanoylphorbitol-13-acetate (TPA), orange oil
and d-limonene all in acetone mixture. Before the 10* week post-initiation, they weight
the treated animals and during the initial 4 weeks, they monitored the diet intake and
observed that no palpillomas developed in the treated mice given either orange oil or dlimonene after initiation with DMBA. In animals that were induced with DMBA
followed by TP A, the rate o f papilloma development was observed to be higher than their
first observations and that high rate o f papilloma occurrence was result o f the
effectiveness o f orange oil compared to d-limonene (Elegbede et al., 1986). In another
study using 3 day old female W istar-Furth rats Elegbede et al (1993), used limonene
(5%) and sorbrerol (1%) to study the blocking effect when DMBA is used to initiates
carcinogenesis. The liver enzymes glutathione transferase (GST) and uridine
diphosphoglucuronosyl transferase (UDPGT) fimction in the liver to prevent carcinogen
interaction with DNA. They used the level o f detoxification enzymes to measure the
effectiveness o f limonene intake. Both the limonene and sobrerol were reported to
increase the activity o f GST and UDPGT in rat livers (Elegbede et al., 1993). Another
observation was that both limonene and/or sorbrerol diets significantly (P<0.05) caused
the level o f non-protein sulfhydryls to be elevated compared to the glutathione levels
observed earlier (Elegbede et al., 1993).
To further elucidate the chemopreventive activities o f monoterpenes Haag and Gould
(1994) used 70 Wistar-Furth rats to investigate the preventive effect o f administering
POH on rats given DMBA to initiate papilloma development. “Complete regression was
defined as the nonpalpability o f the tumor for 3 weeks. Partial regression was defined as
half or less o f the original diameter o f the tumor induced via DMBA that was palpable”
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(Haag and Gould 1994). After first mammary tumor induction, 2.5% POH caused a
complete regression o f the tumor in 22 out o f 27 rats after 3 weeks compared to control
group which had only 9 out o f 29 showing complete tumor regressions (Haag and Gould
1994). In a second study using 215 rats treated with chemical carcinogen DMBA, they
also reported that 1% POH only showed significant level o f tumor regression and the
redifferentiation o f tumor cells observed may have been the POH administered (Haag and
Gould, 1994).
Mills et al. (1995) used Fischer 344 rats treated with diethylnitrosamine (DEN) to
investigate the effect o f POH on carcinogenesis. After 19 weeks o f daily replacing the
POH, they found out that the mean liver tumor weights o f the rats treated with POH were
about 10-fold less compared with control animals. To elucidate the possible means of
action in the liver tumor, they confirmed that POH induced apoptosis, caused increased
levels o f manaose-6 phosphate/insulin growth factor and transforming growth factor p
type I, II and III receptors in all the treated groups (Mills et al., 1995).

2.3 Biosynthesis o f monoterpene from mevalonate pathway
There are two distinct pathways that plants used for the biosynthesis of
monoterpenes. One pathway involves the condensation reaction occurring in the cytosol
o f two acetyl-CoA via the mevalonate pathways to form isopentenylpyrophosphate (IPP)
which is the precursor o f isoprenoids. The other pathway occurs in the plant plastid
involves the condensation o f pyruvate and D-glyceraldehyde-3-phosphate catalyzed to
yield IPP. This reaction is catalyzed by a transferase (as reviewed by McGarvey and
Croteau, 1995).

10

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

o

o
CoA

CoA

+

ACETYL-CoA

H.C

^CoASH

O

H3C

O
CoA

H2C

ACETOACETYL CoA

O

CoA

CoASH

O

OH

6-HYDROXY-6-METHYLGLUTARYL CoA
(HMG-CoA)

CoA

/

O

O

^Hz2'-'

H,C
2'/
H3C

c

r

2NADPH + 2H

^2N A D P
+

o

COASH

OH

H2
O

H,C
/
H3C

H,C
2'-

MEVALONATE

-% .

OH

ATP

O

OH

''

xADP

O

/ S
°

H2C

/

H2C

Nq/

\

5-p h o s p h o m e v a l o n a t e

H3C

Figure 2. Synthesis o f 5-phosphomevalonate from the condensation o f two acetyl-CoA
units via the mevalonate pathway (Adapted from McGarvey, D. J. and Croteau, R. 1995).

11

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

o

OH

5-PHOSPHOMEVALONATE

O
O

ATP

-AD?
O

O

OH "

O

Hz
O

HzC

^

/

-O

II
^P

\

5-PYROPHOSPHOMEVALONATE

O

H,C
ATP

H
CO

O

Jc

V lDP

o
o
Hz
p

P

-o
\

II

H,C

ISOPENTENYLPYROPHOSPHATE (IPP)

O

O

Hz

-o

\\

"O "

" \

DIMETHYLALLYL PYROPHOSPHATE

O
H3C

'

o

+

IPP

O
O

H3C.
H .C'

H
:C

Hz

-o

a

H ,C-

O

/ \ hc
H3C

+ PPi

O

GERANYL PYROPHOSPHATE

Figure 3. Synthesis o f geranyl pyrophosphate from 5-phosphomevalonate, precursor
molecule for monoterpene synthesis (Adapted from McGarvey, D. J. and Croteau, R.
1995).

12

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

0
II

o-

II

p
1
1
0

0

0
1
1
P-

-O

0
PPi

(-)-(S)-LIMONENE

GERANYL DIPHOSPHATE

O 2 + NADPH + H
NADP + HjO

CH 2OH

PERILLYL ALCOHOL

Figure 4. Cyclization o f geranyl pyrophosphate to form the naturally occurring
monoterpenes limonene and perillyl alcohol (Adapted from McGarvey, D. J. and
Croteau, R. 1995).

13

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

The synthesis o f monoterpenes starts with the condensation reaction o f two acetylCoA units catalyzed by acetyl-CoA acetyltransferase to form acetoacetyl-CoA (Goldstein
and Brown, 1990). The HMG-CoA synthase catalyzed the next reaction involving the
addition o f another acetyl-CoA unit to form P-hydroxyl-|3-methylglutaryl-CoA (HMGCoA) (Fig.2, p .l 1). The next step which is “a rate limiting step in cholesterol
biosynthesis in animals” (as reviewed by McGarvey and Croteau, 1995), the HMG-CoA
undergoes a reduction reaction in the presence o f NADPH catalyzed by HMG-CoA
reductase to form mevalonate (Fig.2, p .l 1). Mevalonate is then phosphorylated by the
kinase enzyme called mevalonate kinase to form 5-phosphomevalonate which undergoes
another phosphorylation reaction catalyzed by phosphomevalonate kinase, to form 5pyrophosphomevalonate (Fig.2, p .l 1). This compound is further decarboxylated by the
action o f pyrophosphomevalonate decarboxylase to form isopentenylpyrophosphate, IPP
(Fig.3, p. 12) (as reviewed by McGarvey and Croteau, 1995). The IPP is polymerized
with its isomer 3, 3-dimethylallyl diphosphate by prenyltransferases to form the
monoterpene precursor geranylpyrophosphate (GPP) (Fig.3, p .12). Limonene synthase
catalyzes the cyclization o f geranylpyrophosphate via a dephosphorylation reaction to
form limonene (Fig.4, p. 13). Limonene is catalyzed by limonene 7-monooxygenase to
form perillyl alcohol (oxygenated hydroxyl product) in the presence o f NADPH (Fig.4,
P 13).

2.4

Mechanism o f action

Chemopreventive agents may have either cancer blocking or suppressing activity
against different types o f tumors (Wattenberg 1983 and 1985). Blocking effects occurred
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during the initiation phase o f carcinogenesis to prevent the interaction o f the chemical
carcinogens with DNA via modulating carcinogen metabolism to less toxic forms later
eliminated in the body. The suppressing chemopreventive agents act differently by
preventing the development o f initiated cells during the promotion phase o f
carcinogenesis (Wattenberg, 1985). The mechanism o f tumor regression by
monoterpenes still remains unclear but several cellular activities have been reported to be
related with monoterpenes. These mechanisms are thought to include induction o f cell
cycle arrest or blocking o f the Gi phase, programmed cell death via apoptosis (Shi et al.,
1997) and activation o f phase I and phase II detoxification enzymes (Matlzman et al.,
1991; Austin et al., 1988). Other effects include the inhibition o f the post-translational
modification o f the covalent attachment o f famesyl or geranylgeranyl groups to the
carboxylic terminus o f GTP-binding proteins involved in signal transduction (Clarke et
al., 1992; Crowell et al., 1994). Elegbede et al. (2003), using human carcinoma cell lines
(BroTo and A549), reported the effect o f POH and perillaldehyde (PALD) administered
in vitro for 12 to 24 hr. POH or PALD caused a dose-dependent inhibition o f cell growth
on BroTo and A549 cells (Elegbede et al., 2003). They found that 1.0 and 1.2 mM POH
caused 50% inhibition in BroTo and A549 cells while concentration o f 3.2 and 3.0 mM
for PALD was reported after 24 hr (Elegbede et al., 2003). The mode o f cell death was
via apoptosis when cells were treated with POH, while PALD related cell death was
thought to be through a possible pathway that is yet unknown (Elegbede et al., 2003).
The effect o f POH was reported to be protective against colon cancer and other types of
cancers by induction o f the detoxification enzymes in liver (Maltzman et al., 1991). They
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reported that 5% limonene diet increases the activities o f cytochrome p450 family
members and epoxide hydratase (Maltzman et ah, 1991).
Reddy et al. (1997) studied the effect o f POH on rats induced with the carcinogen
azoxymethane (AOM). They treated rats with AOM after being fed either POH/kg body
weight or saline for two weeks and the rats remain on POH or the vehicle for 55 weeks.
The percentage o f control rats with invasive colon adenocarcinomas was observed to be
greater than the treated group (Reddy et al., 1997). Another observation found was that
the rate o f occurrence and diversity o f noninvasive colon adenocarcinomas in these rats
was unaffected (Reddy et al., 1997). For some unknown reason, they discovered that the
2g POH diet significantly (p<0.001) inhibited the incidence o f total colon
adenocarcinomas and small intestinal adenocarcinoma (Reddy et al., 1997). However,
the apoptotic index was increased by about 5 to 6-fold when rats were given either I g o r
2g POH per body weight diet compared to the control groups (Reddy et al., 1997).
Stayrook et al. (1997) studied the treatment o f malignant hamster pancreatic ductal
epithelial cells and nonmalignant hamster pancreatic ductal epithelial cells with
thymidine incorporation o f POH. From the data acquired, POH caused apoptosis in
malignant cells treated with varying concentrations o f POH. The increase in the
apoptotic populations increased proportionately with increase concentration o f POH
causing higher rates of apoptosis (Stayrook et al., 1997). The population o f cells that
undergo apoptosis in nonmalignant cells was minimal compared to the malignant cells
and POH also caused a two-fold increase in Bak expression in malignant hamster
pancreatic ductal epithelial cells while its expression remained unaltered in non
malignant cells (Stayrook et al., 1997).
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Several human clinical trials conducted have revealed that PA is the most abundant
circulating plasma metabolite followed by DHPA after administration o f POH in humans
(Ripple et al., 1998; Ripple et al., 2000; Murren et al., 2002). Ripple et al. (2000)
conducted a phase I clinical trial o f POH administered to subjects with incidence o f
advanced refractory malignancies. The administration o f POH to these subjects was done
four times per day in a continuous manner at 3 different doses o f SOOmg/m^, 1200mg/m^
and 1600mg/ m^. They administered POH to subjects in soft gelatin capsules containing
250mg o f POH and 250mg o f soya bean oil. They observed an increased in the levels o f
PA and DHPA in the plasma to occur at 1-2.5 hr and 2-3.5 hr respectively after post
ingestion o f POH (Ripple et al., 2000). The level o f plasma metabolite as reported in
their work o f 1998 for PA was found to be predominant than DHPA (Ripple et al., 2000).
After 29 days o f POH administration, they noticed that the level o f PA or DHPA in the
plasma was decreasing with time and the maximum tolerated dose o f POH to be 1200mg/
m^ (Ripple et al., 2000). Chow et al. (2002) using healthy individuals to determine the
systemic availability o f PA when administered with a single dose o f Mediterranean-style
lemonade rich in limonene. They started taking blood samples from subjects before
given them light breakfast containing limonene in the form o f Mediterranean-style
lemonade over a time period o f 10-20 minutes. Blood samples after completion o f the
lemonade intake, were again drawn at different time points and analyzed the level of
limonene in juice and plasma level o f PA. Rapid increased in the plasma level o f PA
after 1 hr consumption was observed and declined rapidly as a function o f time with the
half life o f PA ranging from 0.82 to 1.84 hr (Chow et al., 2002). PA levels were
undetected after 24 hr in all the samples collected (Chow et al., 2002). Brown et al.
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(2000) investigated the effects o f epidermal growth factor receptor (EGFR) in
combination with either cisplatin or 5-fluorouracil (5-FU) on the growth rate o f human
squamous cell carcinoma (SCC) SCC-25 and BroTo cell lines in vitro. They reported
that EGFR are found on the surface o f many different tumor cell lines with IgG
monoclonal antibodies (Mabs). When they treated the cells with cisplatin or 5-FU and
then exposed to different concentrations o f epidermal growth factor receptor (EGFR
Mab), the cell growth of SCC-25 cells was significantly (p < 0.001) decrease compared to
the cells treated with cisplatin alone (Brown et al., 2000). They also reported that both
BroTo and SCC-25 showed significant inhibition with EGFR Mab and 5-FU compared
with 5-FU alone (Brown et al., 2000).
In a study to determine the possible involvement o f PA in cell proliferation, Ferri et
al. (2001) investigated the possible mode o f action o f PA on rat arterial smooth muscle
cells (SMC). When cells were treated with 1- 3mM concentrations o f PA for up to 72 hr,
PA caused a time- and concentration-dependent inhibition of SMC cells and a decrease in
cholesterol biosynthesis in the cells. The incorporation o f mevalonate, femesol or
geranylgeraniol did not influence the inhibition effect exerted by PA (Ferri et al., 2001).
To find out whether the prenyl transferases are the possible target for PA, the
incorporation o f radiolabelled famesol or geranylgeraniol into the cellular proteins was
blocked by PA in the cells. With this result, their concluded was that PA inhibits cell
growth via prevention o f prénylation o f proteins in the SMC cells and the concentrations
o f PA (l-3m M ) that significantly (p<0.01) inhibited SMC cell growth was in correlation
with 0.47 mM plasma concentration that was achieved by Ripples et al. 2000 (p.88) in
their clinical studies using POH on patients with malignancy (Ferri et al., 2001).
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2.4 Combination chemoradiotherapy
It was reported that the sensitivity o f radiation exposure on cell growth in different
types o f cancer cells is dependent on which phase o f the cell cycle the cells are and the
effect o f radiation sensitivity can be improved when used in combination with other
chemotherapeutic agents (Rotman and Aziz 1998). In 1993, Gordon and his group
reported that many chemotherapeutic agents may stop the repair o f radiation damage by
cancer cells which implies the possibility o f synergistic or additive action between
chemotherapeutic agent and radiation when used in combination chemo-radiation therapy
(Gordon et al., 1993). Combination treatment using drugs and radiation has been tested in
clinical practice in malignant tumors (Rotman and Aziz 1998 and Yokes et al., 2000).
Many randomized clinical trials were performed with drugs and radiation which indicated
that certain chemotherapeutic agents have the ability to inhibit radiation resistance seen in
other types o f cancer cells thereby improving sensitization to radiation effect (Kim et al.,

2000 ).
Kies et al., (2001) studied the use o f combining drug and radiation in the treatment o f
head and neck cancer and reported that the intense radiation exposure and chemotherapy
drugs, when delivered together in concurrent combination treatment was highly
successful at controlling the local spread o f head and neck cancer in subjects with this
advanced disease (Kies et al., 2001). They reported that when they combined the known
chemotherapeutic drugs (paclitaxel, fluorouracil and hydroxyurea) with a prolonged
twice daily radiation treatment, the outcome was a successful management o f the local
and regional spread o f head and neck cancer in about 90% o f the patients (Kies et al.,
2001). The overall survival rate o f 55% observed at three years, which they said was
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encouraging, but the treatment could not prevent distant metastasis which occurs in 20%
o f patients (Kies et ah, 2001). Even though they maintained that the study was an
improvement in treatment o f head and neck cancer, the particular drugs used were too
toxic to the patients which led to death o f other patients. In all the subjects used for this
studied, 81% was reported to experience temporary severe drops in white blood cells and
platelets, which is common with chemotherapy and a severe constrained to eat normally
for at least a year (Kies et ah, 2001).
In a current study by Yokes et ah, (2003) combination chemo-radiation therapy was
performed with patients with stage lY head and neck cancer. They administered 6 doses
o f carboplatin and paclitaxel weekly followed by twice daily radiation dose at 1.50 Gy
per fraction for 5 cycles. They observed high response rate and reduction in distant
failures rates among the subjects (Yokes et ah, 2003) and concluded that a treatment
approach which caused high survival rates and progression with preservation o f organ in
a population o f stage lY patients with advanced locoregionally carcinoma o f the head and
neck cancer has been elucidated (Yokes et ah, 2003). A phase II trial was carried out
using chemoradiotherapy in order to achieve locoregional control o f head and neck
cancer with high survival rate and preservation o f organ. Patients were treated with
cisplatin administered every 28 days, followed by 5 days infusional fluorouracil and 12 hr
oral administration o f hydroxyurea for 11 doses before 5 days twice daily radiation
exposure at 1.5 Gy per fraction. Subjects with locoregional advanced stage lY o f the head
and neck cancer were selected specially those with cancer o f the larynx, oral cavity,
paranasal sinuses, cervical esophagus and pharynx. It was reported that treatment using
chemo-radiotherapy results in a locoregional control rate that exceeds 90% among the
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subjects (Yokes et al., 2003). Their conclusion was that using agent that are less toxic to
subjects in combination therapy, toxicity can be avoided when used in future studies and,
possibly, radiation protective agents (Yokes et al., 2003).
The HNSCC account “for approximately 45,000 new cases and 13,000 deaths per
year in United States” (Cancer Facts and Figures 2004). Most o f these cancers begin in
the oral cavity and the traditional treatment option for locally advanced HNSCC is
surgery followed by intensive radiation regimen. However, these treatment modalities
are associated with high morbidity with low survival rates (Stupp et al., 1987). “The way
a particular head and neck cancer response to any treatment options depends on the
primary site o f occurrence in the body. For instance, cancers that initiate on the vocal
cords behave in a differently manner than do those that arise in the larynx indicating
different response rates” (Al-Sarraf M., 1988; Landis et al., 1998). Squamous cell
carcinoma is the most common type o f head and neck cancer which arises in the cells that
line the inside o f the oral cavity, throat and nose. The uncommon types o f head and neck
cancers include sarcomas salivary gland tumors and lymphomas (Landis et al., 1998).
The three main types o f treatment options for head and neck cancer was reported to
include radiotherapy, surgery and chemotherapy. The primary treatment option for head
and neck cancer are radiation therapy or surgery, or combination o f the two; with
chemotherapy sometimes used as an adjuvant (Landis et al., 1998). The best treatment
option for a particular head and neck cancer depends on the time o f diagnosis, site o f
incidense and the extent o f the tumor developed (Landis et al., 1998). Recent findings in
using drugs and radiation indicate that combination o f chemotherapy given at the same
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time with radiation therapy exhibited a more effective treatment option with higher
survival rates than either single traditional treatment modality (Yokes et al., 2003).
Rajesh et al., (2003a) first tested the importance o f POH as sensitizer in radio- and
chemo-sensitization treatment using malignant glioma cell lines. Concentration of
0.5mM POH and 5.5 Gy dose o f radiation were used in combination treatment on glioma
cells to test the effect o f pretreatment o f POH as radio-sensitizer. They pretreated cells
with POH at intervals o f 2 and 24 hr and then irradiated the cells with 5.5 Gy and the
cells were immediately replated for 2 weeks in tissue culture plate with fresh medium.
After incubation, the earliest onset o f radio-sensitization by POH was observed after 8 hr
of treatment (Rajesh et al., 2003a). Cell cycle analysis on glioma cell line (T98G) treated
with POH caused a dose and time-dependent increase in suh-Go/Gi cell population and a
block at G 2/M phase o f the cell cycle (Rajesh et al., 2003a). Cells treated with 1 mM
POH exhibited increased in early apoptotic population positive for AnnexinY only. Their
data indicated that apoptosis and radio-sensitization o f glioma cells by POH was via the
expression o f Fas ligand and Fas receptor (Rajesh et al., 2003a). In another study, Rajesh
et al. (2003b) using prostate cancer cells, cells were treated with 0.1-0.5 mM POH for a
period o f 72 hr and then exposed to different doses o f radiation. They observed a
significant reduction o f the cell growth in DU 145 and PC-3 cells when treated with
concentrations between 0.7 and 1 mM POH (Rajesh et ah, 2003). Pretreatment o f these
cells with POH also elicited a dose- and time-dependent sensitization o f the prostate
cancer cells to radiation (Rajesh et al 2003b). The authors then treated DU 145 and PC-3
cells with POH for 72 hr in the presence and absence o f 5.5 Gy dose o f radiation. They
reported an increase in the population o f cells in sub-Go/Gi and early apoptotic cells
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positive for Annexin V (Rajesh et al., 2003b). They also reported an increase in the
G 2/M phase and a decrease in the Gq/Gi phase o f the cell cycle which appeared to
precede the onset o f apoptosis in both DU 145 and PC-3 (Rajesh et al., 2003b). Treatment
with POH also caused an increased expression o f cyclin D1 (Rajesh et al., 2003b). One
interesting finding was that POH did not alter the level o f Fas receptor expression in all
the prostrate cancer cells (Rajesh et al., 2003b).
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CHAPTER 3

MATERIALS AND METHODS
3.1

Chemicals and reagents

Perillyl alcohol (4-isopropenyl-cyclohexenecarbinol) and perillic acid (4-isoprepenylI-cyclohexene-1- carboxylic acid) were procured from Aldrich Chemical Co.
(Milwaukee, WI). Phosphate buffered saline (PBS; lacking Ca^^ and Mg^^), penicillin
(100 units/ml) and lOOpg/ml streptomycin (P/S) and trypsin-EDTA were purchased from
Invitrogen Corporation (Grand Island, NY). AlamarBlue dye was obtained from
Biosource Intl. Inc. (Camarillo, CA). Propidium iodide (PI) and ribonuclease A (RNase
A) were obtained from Sigma Chemicals (St. Louis, MO). Fetal bovine serum was
purchased from HyClone Laboratories (Logan, UT). DM EM/F-I2, RPMI and M EM -a
media were purchased from Invitrogen Corporation (Grand Island, NY). Standard
diluent buffer (contains 15 mM sodium azide), p53 standard, rabbit anti-p53 (detection
antibody containing 15 mM sodium azide), anti-rabbit IgG-Horseradish peroxidase
(HRP) containing 3.3 mM thymol, HRP diluent (contains 3.3 mM thymol, wash buffer
concentrate (25x), stabilized chromogen (tetramethylbenzidine) and stop solution were
procured from BioSource hitemational Inc. (California, USA). BCA protein assay
reagent kit was obtained from Pierce (Rockford, IL).
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3.2 Cells and cell culture
Human squamous cell carcinoma o f the tongue, SCC-25 procured (ATCC Rockville,
MD), BroTo (a gift from J. Truelson, MD, Department o f Otolaryngology, University o f
Texas, South-western Medical Center) and human squamous cell carcinoma o f the
pharynx HTB-43 (ATCC Rockville, MD) were used in these studies. T-Lymphocytes
cells, Jurkat cells (a gift from Dr. S. Carper), was also used as control cell line for
Annexin-V flow cytometry. Cells were cultured in DMEM/F-12 (SCC-25), RPMI
(BroTo), M EM -a (HTB-43) or RPMI 1640 (Jurkat) supplemented with 10% FBS and 1%
P/S. Cells were dislodged with trypsin-EDTA and the indicated numbers o f cells were
plated in tissue culture plates and allowed to adhere overnight. Stock (IM ) solutions o f
POH and PA were prepared by dissolving each agent in dimethyl sulfoxide (DMSO).
Treatment media were prepared by diluting the stock solution in medium to give the
desired concentration and allowed to solubilize at 37*^C for 1 hr with occasional mixing.
Cells in the control groups received medium containing DMSO. Cells treated with
various concentration o f each agent were incubated in humidified, 5% CO 2atmosphere at
37°C.
3.3 Dye-exclusion assay
Two million cells were cultured in each o f 100mm tissue culture plates and allowed
to adhere overnight. Cells were then treated with varying concentrations o f agents for 72
hr. Control cells received medium with DMSO (<0.I% ; v/v) only. Control, PA- and
POH-treated groups were exposed to I Gy or 2Gy dose o f irradiation source (X-ray, 6MV
Varian C linacl/100 Palto Alto, CA) and were incubated overnight at 37°C in humidified
5% CO 2atmosphere. Cells were harvested with trypsin-EDTA and centrifuged at 840

25

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

rpm (Allegra™ 6KR Centrifuge, Palo Alto, CA). Live cells were counted on a
hemocytometer. The effect of different treatments on cell proliferation was measured by
directly counting the number o f live cells that excluded trypan blue dye.

3.4

Mitochondrial dehydrogenase assay

A modified method for the determination o f mitochondrial dehydrogenase activity in
live cells was used according to the manufacturer’s instruction. The alamarBlue assay
incorporates the REDOX indicators that both fluoresce and change color (fi-om blue to
red) due to the chemical reduction o f the growth medium resulting from cell proliferation
(Fields and Lancaster 1993.). Cells (5000 cells/well) were plated in 96-well plates and
allowed to adhere overnight. The following day, the culture medium was replaced with
medium (100 pi) containing the desired concentration o f POH or PA and incubated at
37°C in humidified CO 2 atmosphere for 24, 48 or 72 hr. At the end o f the exposure
period, the treatment medium was replaced with lOOpl o f fi-esh medium and lOpl o f the
alamarBlue dye in each well and the cells incubated at 37°C in 5% CO 2 atmosphere for at
least 4hr. Fluorescence was measured after excitation at 530nm wavelength and emission
at 590nm wavelength using GENios fluorescence plate reader (PHENIX Research
Product, Hayward, CA). Cytotoxicity was assessed by comparing the fluorescence
intensity data from calculating the viable cells in the treatment group relative to the
control groups (100%).
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3.5

Clonogenic assay

Cells (2 X 10^) cultured overnight in 100mm tissue culture plate were similarly treated
with or without 1.0 mM PA or 0.5 mM POH for 72 hr and exposed to IG y or 2Gy doses
o f radiation as described earlier (p.25) and clonogenic or colony formation assay (CFA)
was performed as described by Elegbede et al. 2003 (see Ref. 17, p.84) to determine the
long-term effects o f the monoterpenes on the proliferation of cancer cells. Cells were
washed twice with sterile PBS and the complete culture medium after incubation. Cells
(500/well) were then cultured in 6-well tissue culture plates. Fresh, complete culture
medium was then added to each well and the cells were incubated for 10-14 days at 37°C
in humidified, 5% CO 2atmosphere. Cells were observed every other day to monitor cell
growth. At termination, the culture medium was removed, the cells were rinsed with
PBS, stained with crystal violet (5mg/ml in 95% ethanol) and the dye gently rinsed off
and allowed to dry. Colonies, containing at least 50 cells, were counted in each well and
the cell viability was calculated as a percentage o f the number o f colonies formed in the
treatment group relative to the control (100%).

3.6

Combination Chemo-irradiation studies

One thousand cells were plated in 96-well tissue culture plates overnight for cells to
adhere. The culture medium was replaced with fresh 200pl culture medium. Cells were
then irradiated with varying doses o f X-ray, from 0, 1, 2, 3, 5 and 8Gy (6 MV Varian
Clinac 1/100, Palto Alto, CA). After radiation, cells were then incubated overnight at
37°C in humidified 5% CO 2atmosphere. Treatment medium was replaced with fresh
completes medium (100 pi) and incubated for 5 days before performing alamarBlue assay
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as described earlier (p.26). For effects o f combination treatment, cells were cultured
either in 100 mm (2 million cells each) or in 6-well (500 cells/well) plates and were
treated without (control) or with PA or POH. In one set o f experiments, cells were
exposed to 1 or 2Gy o f X-ray (6 MV Varian Clinac 1/100, Palo Alto, CA) while in the
other set the cells were not irradiated. Following irradiation, the cells were incubated for
12 to 15 hr at 37°C in humidified, 5% CO 2atmosphere. All the cells were harvested and
used for dye exclusion or colony formation assays and cell cycle analysis as described
(p.26 and p.28).

3.7

Cell cycle analysis

To determine whether the monoterpenes affect cell cycle or apoptosis, cells (5 x 10^
/well) were cultured in 6-well plate overnight at 37°C in humidified, 5% CO 2 atmosphere.
Cells were then treated with 1.0 mM PA or 0.5 mM POH for 24 hr or 72 hr. After
incubation (as described by Elegbede et al., 2003, p.85), cells were harvested, fixed in
90% ethanol and kept at 4°C prior to analysis. For cell cycle analysis, the cells were
stained with the DNA staining solution (150pg/ml PI, 0.1% Triton X-100, and Img/ml
RNase A (DNase-free) in PBS, 1:1:1 by volume). The DNA contents o f the control and
treated cells were measured by flow cytometry following propidium iodide staining using
a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). Twenty thousand
events were acquired and the proportion o f hypodiploid (sub-Go/Gi) events and cells in
Go/Gi, S and G 2/M phases o f the cell cycle were determined using the DNA analysis
software ModFit LT 3.0 (Verity Software House, Topsham, ME).
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3.8 Apoptosis assay
Cells (Ix 10^ cells/ plate) were plated overnight and treated with 0.5 mM POH or 1.0
mM PA for 72 hr. Both control and treated cells were harvested after incubation and
washed with cold PBS at 400x g for 5 min. Pellets were resuspended in cold PBS and
counted. According to the manufacturer’s instruction, the numbers o f cells was adjusted
to approximately 500,000 cells per ml before pelleting at 400x mg for 5 min. Pellets
were then washed in 2.0 ml x 1 Annexin-V Binding buffer (BD PHARMINGEN, San
Jose, CA) at 500 x mg for 5 min. The pellets were treated with Annexin-V-FITC
conjugated (BD PHARMESfGEN, San Jose, CA) and incubated in the dark for 15 min.
The treated mixture contains 5 pi o f Annexin V conjugated to approximately 500,000
cells in 1pi fetal bovine serum. The volume o f cells with Annexin V conjugated mixture
was then adjusted up with addition o f 450pl o f x 1 Annexin-V binding buffer, (each tube
contains cells-conjugate mixture o f approximately 500pL). Acquisition to discriminate
between apoptotic and necrotic or dead cells was done by staining the cells-conjugate
mixture with lOpL PI solution (500pg/ml) (BD PHARMINGEN, San Jose, CA).
Acquisition was done on B D ’s FACS Calibur cytometry on the FLI (Annexin) and FL3
(PI) channels with threshold on FSC and Duplet Discriminating Module (DDM) set at
FLI. The level o f shift in events distribution in the treated cells stained with Annexin-V
only and Annexin-V-PI populations in comparison to untreated controls is indicative o f
degree o f effectiveness of the treatment agent(s). Numeric quantitations o f these events
are accomplished with population gating.
We further visualized apoptotic cells using detection system from Phoenix Flow
System Inc. according to the manufacturer’s instructions. Cells (HTB-43, SCC-25 or
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Jurkat T-lymphocyte,) were fixed with formaldehyde to retain (crosslink) fragmented
DNA within apoptotic cells. The 3'OH termini o f DNA strand breaks were labeled with
BrdUTP in the reaction catalyzed by the terminal deoxynucleotidyl transferase (TdT);
cellular DNA was counterstained with PI and DNA content was measured using 488 nm
laser excitation in FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). To
calculate the percentage o f cells in the respective phases o f the cell cycle, the DNA
content frequency histograms were deconvoluted using the MultiCycle software (Phoenix
Flow Systems, San Diego, CA).

3.9

Cell lysate preparation

Cells were plated and allowed to stay overnight. The following day, the medium was
aspirated off and cells were treated with 0.5 mM POH or I.O mM PA for 72 hr. Cells
were then exposed to IG y or 2Gy dose o f irradiation and incubated overnight. Cells were
harvested and transferred into a 15 ml centrifuge tube. The cells were then centrifuged at
840 rpm for 5 minutes and media was aspirated off. The pellets were resuspended and
then washed three times with 5 ml o f cold PBS. The pellets were resuspended in 1ml o f
PBS and were transferred into a microfuge tube and then centrifuged at 13,000 rpm
(BECKMAN Microfuge® R Centrifuge, Palo Alto, CA) for 10 minutes at 4°C and stored
at -80°C for protein analysis. Cells were thawed and lysed in cell extraction buffer
(containing protease inhibitor and PMSF) for 30 minutes on ice while vortexing at 10
minutes interval (according to Pierce BCA protein assay, Rockford, IL). The extracts are
then transferred into microcentrifuge tubes and centrifuged at 13,000 rpm for 10 minutes
at 4°C. Aliquoted the clear lysate into clean microcentrifuge tubes and assayed.
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3.10 Determination o f p53 protein in HNSCC cells.
The protein concentration o f each sample was determined using BCA protein assay
according to the manufacturer’s instruction. Different dilutions o f bovine serum albumin
(BSA) standards were prepared (0, 25, 125, 250, 500, 750, 1000, 1500 and 2000pg/ml)
and 25 pi each o f prepared BSA standards or samples (lOpl o f cell lysate and 15pl diluent
PBS) were then pipetted into 96-well microtiter wells and 200pl o f BCA working reagent
was then added into all wells and incubated for 30 minutes at room temperature and the
absorbance was measured at 570 nm wavelength using ELISA plate reader. Protein
concentration o f each sample was then calculated from the absorbance reading. The p53
protein was determined and quantified using Biosource p53 ELISA according to the
manufacturers instructions. Standard diluent buffer (100pi) were added to zero wells in
p53 antibody-coated wells and well(s) reserved for chromagen blank was left empty.
Standards, samples or controls (100pi) were then pipetted into their appropriate reserved
wells. The plate was covered and incubated for 2 hr at room temperature. The extracts
were diluted in cell extraction buffer (5pi sample into 95pi). After incubation, the
solution was aspirated off from the wells and each well was washed 4 times with wash
buffer. One hundred microliter o f anti-p53 (detection antibody) solution into each well
except the chromogen blank(s) and mixed gently. The plates were covered and incubated
for 1 hr at room temperature. The solution was again aspirated from each well and each
well washed again 4 times with wash buffer. Anti-rabbit IgG-HRP (lOOpl) working
solution was transferred into each well except the chromogen blank(s) before incubating
for 30 minutes at room temperature. Solutions were again aspirated o ff from the wells
and washed 4 times with wash buffer. Standard chromogen (100 pi) to each well
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including the chromogen wells and plates were further incubated for 30 minutes at room
temperature in the dark. The stop solution (100 pi) was then added into to each well and
mixed gently until solution change from blue to yellow. The absorbance was read on
GENios plate reader at 450 nm wavelength against a chromogen blank. Absorbance o f
each sample was calculated to quantify the level o f p53 protein (according to
manufacturer’s instruction using BioSource p53 (Total) ELISA assay).

3.11

Statistical analyses

Results are expressed as Mean ± SD o f replicate analyses. The effectiveness o f
treatment methods and combination treatments were analyzed using ANOVA. Dunnett’s
two-sided test (at a = 0.01) was used to evaluate differences in the effects between POH,
PA and the controls. The effectiveness o f POH compared to control or PA was
determined by Turkey’s least significant difference (LSD). Differences with p-value less
than 0.01 (p<0.01) were considered statistically significant. The combination treatment
act with significant difference (ANOVA at a =0.01) in each cell line (HTB-43, SCC-25
and BroTo) and method while both treatment factors (monoterpenes and radiation) are
significant on the rate o f effectiveness (ANOVA at a = 0.01). Comparison with control,
both PA and POH are significantly different from control (Dunnetts two sided test
a t <2 = 0.01). Comparison o f compounds with each other, POH results in the highest rate
o f effectiveness than PA in all the cell lines (Turkey’s LSD ay « = O.OI). Comparison o f
radiation, IG y o f radiation results in significantly better effectiveness than no radiation in
combination treatment (ANOVA at « = 0.01).
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CHAPTER 4

FINDINGS OF THE STUDY
4.1

Analysis o f results

The cytotoxicity effect o f PA and POH was determined by alamarBlue assay in
HNSCC cells exposed for 24, 48 and 72 hr time point. Treatment with 1.0 mM PA and
0.5 mM POH caused a dose- and time-dependent inhibition with greater effect observed
after 72 hr on HTB-43 (19% and 51%), SCC-25 (24% and 63%) and BroTo (31% and
40%) cells respectively (Fig. 5, p.38)
To determine the effect o f radiation on cell proliferation, cells were exposed to
numerous dose o f radiation from IG y to 8Gy. A dose dependent inhibition on cell
proliferation was observed with IGy as follows: HTB-43 (20%)>SCC-25 (8%)>BroTo
(5%) respectively (Fig. 6, p.39). Drastic inhibition was seen with 8Gy dose (Fig.6, p.39).
Radio-sensitization was designed with 1.0 mM PA and 0.5 mM POH. Dye-exclusion
and colony formation assay were employed to test the effects o f either monoterpenes
alone or irradiation or combination o f both on these cell lines. Pretreatment with 1.0 mM
PA reduced the number o f viable cells by 10% in H T B -43,19% in SCC-25 and 9% in
BroTo cells respectively. Exposure o f these cell lines to 2Gy dose o f irradiation alone
minimally reduced the viability o f these cells (Fig. 7, p. 40). When the cells were
pretreated with 1.0 mM PA or 0.5 mM POH and exposed to IGy dose o f radiation the
viability o f each cell line was reduced as follows; HTB-43 (50% and 71%), SCC-25
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(55% and 68%) and BroTo (18% and 53%) respectively (Fig. 7, p. 40). Similar results
were obtained when the cells were pretreated with POH or PA and then exposed to 2Gy
dose o f irradiation (Fig. 7, p.40).
The long-term survival o f cells from 12 to 14 days, when pretreated with
monoterpenes followed by irradiation was also investigated. Figure 8 (p.41) shows the
quantitative effect o f the respective treatments on the cell lines. Fewer colonies were
formed in groups pretreated with monoterpenes and exposed to irradiation compared to
either the control (no treatment, radiation alone or chemotherapy alone) (Fig. 8, p.41).
SCC-25 cells formed the fewest colonies o f all the cell lines (Fig.8, p.41). Quantitative
examination o f the results (Fig. 9, p.42) showed that pretreatment with monoterpenes
followed by exposure to irradiation further inhibited proliferation o f the HNSCC cells.
The respective inhibition o f proliferation in HTB-43, SCC-25, and BroTo cells were PA
(35, 45, 30%) and for POH (60, 55, and 40%) respectively when exposed to IGy o f
irradiation (Fig.9, p.42).
To determine the effects o f the treatment on the cell cycle progression, we performed
cell cycle analysis on treated cells using a FACSCalibur flow cytometry (Becton
Dickson, San Jose, CA) following propidium iodide staining. At 24 hr, POH treatment
induced a block in the G q/G i phase in all the three cell lines at 24 hr while PA treatment
blocked only BroTo cells in G q/G i but no such effect on the other cell lines (Table 1,
p.43). At 72 hr, PA induced some G q/G i arrest in all cell lines (Table 1, p.43). Figure 10
(p.44) shows a plot o f the apoptotic index versus different treatments. Apoptotic index
(AI) was calculated as a ratio o f the mean apoptosis values in the treated groups divided
by the mean apoptosis values o f respective control for each cell line. Calculation o f the
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AI normalized the treatment effect for each cell line, thereby facilitating a comparison
between them. AI was highest for SCC-25 cells treated with POH and exposed to 2Gy
dose of irradiation (Fig. 10, p.44). The overall sensitivity o f the cell lines were for POH:
SCC-25>BroTo>HTB-43 and for PA: HTB-43>SCC-25>BroTo respectively (Fig. 10,
p.44).
To confirm PA or POH induced cell death, both Annexin V (AV) and propidium
iodide (PI) staining by flow cytometry was performed with HTB-43, SCC-25 and BroTo
cells exposed to l.OmM PA and 0.5 mM POH for 72 hr exposure. Jurkat T-Lymphocytes
cells were used as control cell line. The lower left quadrant o f the cytograms shows the
viable cells, which exclude PI and are negative for FITC-Annexin V binding. The upper
right quadrant represents the non-viable, necrotic cells, positive for FITC-Annexin V
binding and showing PI uptake. The lower right quadrant represents the apoptotic cells,
FITC-Annexin V positive and PI negative, demonstrating Annexin V binding and
cytoplasmic membrane integrity. The percentage o f cells single positive for FITCannexin V binding after treatment with 1.0 mM PA or 0.5 mM POH was 5.9 and 17.9%
for Jurkat cells (F ig .ll, p. 45), 38.8 and 49.8% for HTB-43 (Fig. 12, p.46.), SCC-25
having 13.8 and 23.8% (Fig.l3, p.47) and for BroTo cells 1.5% and 0.6% (Fig. 14, p.48).
We observed high percentage o f late apoptotic cells, double positive for both FITCannexin V/Pl in BroTo cells compare to early apoptotic cells (Fig. 14, p.48).
To discriminate apoptotic cells from necrotic cells, we further visualized apoptotic
cells using detection system fi’om Phoenix Flow System Inc. The percentage o f live and
apoptotic cells were quantified using the MultiCycle software. Our data showed that in
the control cell line (Jurkat cells) only 0.6% and 0.7% o f cells were apoptotic compared
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to live cells (Fig. 15, p.49) while for HTB-43 the percentage o f apoptotic cells for PA and
POH treatment was 77.2 and 63.5% respectively (Fig. 16, p.50). In SCC-25 cells
treatment with 1.0 mM PA and 0.5 mM POH for 72 hr resulted in 62.3 and 78.0% of
apoptotic cells (Fig. 17, p.51).

4.2

Initial attempt to quantify p53

When the DNA o f a cell is damage due to either radiation or agent, the tumor
suppressor protein, p53 is activated for repair process. The p53 gene is the most
commonly mutated gene in human cancers especially in head and neck cancers. In 1996,
Kiuru et al. and colleagues affirm that since p53 is highly mutated in HNSCC, this will
probably account for their sensitivity or resistance to either radiation or agent. In an
attempt to detect or quantify the level o f p53 in HNSCC cells, HTB-43, BroTo, and SCC25 cells were treated with PA or POH alone or radiation alone or combination o f both.
We identified and quantified the p53 protein level in HNSCC cells using the BioSource
p53 (Total) immunoassay called Enzyme Linked-lmmuno-Sorbent Assay (ELISA) by
referring to a standard curve (plotted in Fig. 18, p.53). With HTB-43 and BroTo cells
override was observed, meaning that the fluorescence signal exceeded the range for
detection by the instrument. This was probably due to high level o f p53 proteins
expressed in these two cell lines compared to SCC-25 cells. W ith SCC-25, the result
indicated that the level o f p53 in the control was higher than the treated group (Table 2
and Fig. 18, p.52 and p.53). However, these results may not be reliable. Observed protein
levels should be proportional to the number o f cells. We expect the protein in the control
group to be higher than in the treatment groups because cell number should be greater in
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the control than treated groups due to cell death caused by the agent (for example, see
Figure 7, p.40). But we observed that the protein level in the treatment groups was
higher than the control, suggesting that some type o f error may have occurred during this
experiment. Furthermore, it could be that SCC-25 cells express very little or no p53.
Min et al. (1994) reported that the squamous cell carcinomas o f the tongue, SCC-25 have
p53 levels that are not easily detected. They also reported a p53 mutation observed in
SCC-25 due to deletion at codon 209 o f two base pairs (Min et al., 1994). There is need
for further investigation o f the p53 protein using western blotting technique, and
repeating the ELISA. In addition to SCC-25, it may be desirable to look again at more
diluted samples from HTB-43 and BroTo cells, which appear to have high concentrations
of p53.
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Figure 5. Inhibition effects o f monoterpenes on human head and neck cancer cells. Cells
were plated in tissue culture plates and exposed to equimolar concentrations o f PA or
POH for 24, 48 and 72 hr. AlamarBlue assay was used as described in the text to
measure the cytotoxicity o f each agent. Values represent Mean ± SD (n=4).
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Figure 6. The response o f head and neck squamous cell carcinoma cells to radiation
exposure. HTB-43, SCC-25 and BroTo cells were plated separately in tissue culture plate
and exposed to different doses o f irradiation from 1 to 8Gy and allowed to stay overnight.
Treatment medium and cells were incubated for 5 days. At termination, the effect of
radiation exposure was determined by alamarBlue assay as described in the text. Graph
represent Mean ± SD (n=4).
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Figure 7. Monoterpenes sensitized FINSCC cell lines to radiation treatment in vitro. Cell
lines were treated with 1.0 mM PA or 0.5 mM POH for 72 hr then exposed to IGy or
2Gy o f X-ray dose. Control cells with or without monoterpenes received no irradiation.
Cells were harvested, stained with trypan blue dye and proportion o f viable cells relative
to the control was determined. The graph represent Mean ± SD (n=3) o f % viability
versus treatment regimen.
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Figure 8. Colony formation in HNSCC cells after combination treatment with
monoterpenes and radiation. HNSCC cells (SCC-25, BroTo, HTB-43) were exposed to
0.5mM perillyl alcohol (POH) or l.OmM perillic acid (PA) for 72 hr and then exposed to
0, 1, or 2Gy X-ray. Cells were harvested, washed with PBS, and cultured in 6-well plates
(500/well) with complete medium for 14 days. Cells were stained with crystal violet and
colonies, containing at least 50 cells, were counted. Cell viability was calculated as
percentage o f the colonies in treated group relative to that of the control groups.
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24 hr
Cell line

Treatment

Go/Gi

S

HTB-43

Control

77.7
± 0 .5
81.5
± 1.8
74.9
± 1.3
46.4
± 2.6
60.9
± 2 .5
46.7
± 0 .5
58.1
± 1.0
72.4
± 2 .9
72.4
± 5.15

9.7
± 1.8

0.5 mM POH
1.0 mM PA
SCC-25

Control
0.5 mM POH
l.O m M P A

BroTo

Control
0.5 mM POH
1.0 mM PA

0.2

± 0.1
14.7
± 0.8
37.2
± 1.4
36.7
± 5 .2
41.0
± 1.7
26.2
± 4 .4
17.8
± 2 .9
21.1

± 5 .4

72 hr
G 2/M

Go/G,

S

G 2/M

12.6

43.5
± 1.0
49.5
± 0 .9
49.4
± 0.8
43.3
± 2 .7
52.5
± 1.62
62.9
± 1 .7
60.9
± 0 .3
57.4
± 0 .7

44.0
± 1.2
36.9
± 1.2
36.2
± 0.6
37.6
± 0 .7
39.1
± 1.1
36.9
± 0 .7
30.2
± 0 .4
33.1
± 0 .5

12.5
± 0 .7
13.6
± 0 .5
13.6
± 0 .5
19.2
± 3 .5
8.5
±2.3
14.6
± 1.4
8.8
± 0.1
9.5
± 0 .3
9.8
± 0 .3

± 2 .3
18.6
± 1.3
10.4
± 2.0
16.4
± 1.4
2.4
± 2 .7
12.3
± 2.2
15.8
± 5 .4
9.7
± 2 .5
6.5
± 0 .3

68.0

± 0.25

22.2

±

0.2

Tables 1. Cell cycle distribution o f HNSCC cells treated with monoterpenes. HNSCC
Cells were harvested after exposure to perillic acid (PA) or perillyl alcohol (POH) for 24
or 72 hr. The cells were fixed in ethanol and stained with propidium iodide. DNA
content data were acquired using BD FACSCalibur and CellQuest acquisition software
(Beckon Dickinson, San Jose, CA). The data were analyzed using ModFit LT version,
3.0 analysis software (Verity software House, Topsham, ME). Values are Mean ± SD
(n=3).The table is representative o f two separate experiments.
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Figure 10. Monoterpenes induced apoptosis in HNSCC cell lines. Human head and neck
cancer cell lines were treated with 1.0 mM perillic acid (PA) and 0.5 mM perillyl alcohol
(POH) for 72 hr. At termination, cells were harvested and washed with PBS. Cells were
fixed in ethanol, washed and stained with propidium iodide and percentage o f cells in
sub- Go/Gi phase o f the cell cycle was quantified using flow cytometry. Figure represent
apoptotic index (AI) calculated as a ratio o f the mean apoptosis values in the treated
groups divided by the mean apoptosis o f respective control for each cell lines. Values
represent two separate experiement
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was done with FACSCalibur flow cytometry. Lower left quadrants o f each point show
the viable cells, which exclude PI and negative for FITC-Annexin V binding. The upper
right quadrants (DP) contain non-viable cells positive for FITC-Annexin V binding and
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Figure 12. HTB-43 cells contour diagram o f FITC-Annexin V/PI flow cytometry treated
for 72 hr. Control and treated cells were harvested and washed with 5 ml wash buffer.
Treated cells with FITC-Annexin V conjugate and stained with PI. Acquisition was done
by flow cytometry. Lower left quadrants o f each point show the viable cells, which
exclude PI and negative for FITC-Annexin V binding. The upper right quadrants (DP)
contain non-viable cells positive for FITC-Annexin V binding and PI uptake. The lower
right quadrants (SP) represent the apoptotic cells, single positive for FITC-Annexin V
and negative PL
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Figure 14. BroTo cells Contour diagram o f FITC-Annexin V/PI flow cytometry o f treated
for 72 hr. Untreated and treated cells were harvested and washed with 5 ml wash buffer.
Cells were treated with FITC-Annexin -V conjugate and stained with PI. Acquisition
was done by flow cytometry. Lower left quadrants o f each point show the viable cells,
which exclude PI and negative for FITC-Annexin V binding. The upper right quadrants
(DP) contain non-viable cells positive for FITC-Annexin V binding and PI uptake. The
lower right quadrants (SP) represent the apoptotic cells, single positive for FITC-Annexin
V and negative PI.
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FigurelS. Jurkat cell death analysis using BrdUTP labelling. Control and treated groups
were exposed for 72 hr, then harvested and washed with 5 ml o f wash buffer. Incubated
cells in DNA labelling for 1 hr at 37°C in water bath. After incubation, cells were rinsed
twiee with 1.0 ml rinsed buffer and resuspended cell pellet in 0.1 ml o f Fluorescein-PRB1 Antibody solution for 30 minutes in the dark. Add 0.5 ml o f propidium iodide/RNase
A solution and incubated for more 30 minutes and eells distribution analyzed was
conducted using flow cytometry. M l and M2 represents live and apoptotic cells.

49

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

o
00

0.04%

I

99.5%

U

M2

Control

o
o
o
o
oo

,77.2%
22.9%

I

M2
1.0 mM PA

U

<N

O
O
o

00

63.5%
o
U

2

38.2%

M2

0.5 mM POH

o
(N
O
F L l-Fluorescein

Figure 16. HTB-43 cell death analysis exposed for 72 hr using BrdUTP labelling.
Untreated and treated group were harvested after treatment and washed with 5 ml o f wash
buffer. Incubated cells in DNA labelling for 1 hr at 37°C in water bath. After incubation,
cells were rinsed twiee with 1.0 ml rinsed buffer and resuspended in 0.1 ml o f
Fluorescein-PRB-1 Antibody solution for 30 minutes in the dark. Added 0.5 ml o f
propidium iodide/RNase A solution and incubated for another 30 minutes. Cells were
analyzed using flow eytometry. M l and M2 represents live and apoptotie cells.
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Figure 17. Cell death analysis o f SCC-25 cells exposed for 72 hr using BrdUTP labelling.
Control and treated cells were harvested after treatment with agent and washed with 5 ml
o f wash buffer. Cells were incubated in DNA labelling for 1 hr at 37oC in water bath.
After incubation, cells were rinsed twice with 1.0 ml rinsed buffer and resuspended in 0.1
ml o f Fluorescein-PRB-1 Antibody solution for 30 minutes in the dark. Added 0.5 ml o f
propidium iodide/RNase A solution and incubated for another 30 minutes. Cells were
analyzed using flow cytometry. M l and M2 represents live and apoptotic cells
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Treatment
Control
0.5 mM POH
l.O m M P A
IGy
2Gy
IGy/PA
2Gy/PA

p53
pg/5pl
373.1
191.63
69.34
59.58
53.64
54.55
78.15

Protein
ug/5pl
&83
9.83
12.49
845
15.06
21.36
14.53

Pg/pg
protein
54.63
19.5
5.55

% o f p53
level

% reduction
o f p53 level

100

0

35.7

6.66

12.2

3.56
2.55
5.38

6.5
4.1
9.8

64.3
89.8
8T8
93J
95.9
90.2

10.2

Table 2. Reduction o f p53 protein level in SCC-25 cells in culture. Cell samples and
standards were added to microtiter wells coated with p53 antibody and incubated for 2
hours. Aspirated solution in wells washed 4 x with wash buffer and pipetted 100 pi antip53 detection antibody in to wells except chromagen blanks. Covered plate and
incubated for 1 hour. Aspirated off solution, washed wells 4x with wash buffer and
added 100 pi anti-rabbit IgG-HRP working solution and incubated for 30 minutes.
Washed and added standard chromagen to all wells, incubated for 30 minutes in the dark
at room temperature. Added stop solution to each well and read the absorbance at 450
nm. Table represents average o f duplicate reading for p53 protein level.
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Figure 18. The expression o f p53 protein in SCC-25 cells following chemo-radiation
treatment with monoterpenes: Added lOOpl (5pi sample into 95pi) o f sample in
appropriate microtiter wells and incubated for 2 hrs. Pipitted lOOpl o f anti-p53 into each
well after washing with buffer. Covered and incubated plate for 1 hr. Washes 4x with
buffer and adds lOOpl o f anti-rabbit IgG-HRP working solution except blank well and
incubates for 30 minutes. Wash 4x with buffer and added lOOpl o f standard chromagen
and incubated in dark for 30 minute. Add lOOpl o f stop solution and Read absorbance at
450 nm. Figure represents values o f the treated groups compared with standard values.
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CHAPTER 5

SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS.
5.1

Discussions o f results

During cell growth, the metabolic activity results in a chemical reduction o f the
alamarBlue dye from blue to red indicating cell viability. Continued cell proliferation
maintains a reduced environment (change o f dye color to red) while inhibition o f growth
maintains an oxidized environment (no change in dye color, blue). Reduction related to
cell growth causes the alamarBlue dye to change from oxidized form to reduced form.
Fluorescence intensity is proportional to the number o f viable cells and comparison o f
this intensity in treated cells to that o f the untreated control is used as a measure o f
cytotoxicity o f PA or POH on cell growth. In this present study, treatment o f HNSCC
cells to either 1.0 mM PA or 0.5 mM POH inhibited the proliferations o f cells in a timedependent manner with drastic effect observed after 72 hr exposure in all the cell lines
(Fig.5, p.39).
We have tested a low dose (0.5 mM) o f POH and physiological achievable level
(1.0 mM) o f PA as agents for use in combination chemo-radiation treatments. POH or
PA alone minimally affected the viability (Fig.7 and 9, p.41 and 43) or proliferation
(Fig.9, p.43) o f HNSCC cells in culture. However, when the cells were pretreated with
each monoterpenes and then exposed to IG y dose o f irradiation, the combination
treatment with PA significantly (p<0.01) reduced the survival o f HTB-43 and SCC-25
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cells (Fig. 7 and 9, p.40 and 42) as well as that o f BroTo cells (p<0.01). The reduction in
viability was as a result of apoptosis induction as shown in Figure 10 (p.45). Induetion o f
apoptosis was assessed as apoptotic index (AI) derived as a ratio o f mean apoptosis
values o f treated cells to that o f the control cells. POH, in combination with irradiation,
induced higher apoptosis than PA (Fig. 10, p.45) although the sensitivity o f the cell lines
appears to take similar trends: SCC-25>HTB-43>BroTo. BroTo cells appeared less
affected by monoterpenes and/or irradiation compared to SCC-25 and HTB-43 cells (Fig.
10, p.45)
In the studies investigating the long-term effects, we found that pretreatment with
monoterpenes followed by irradiation inhibited the proliferation o f the cancer cells (Figs.
8 and

9, p.42 and 43). Our data eonfirm the radio-sensitization effects o f the

monoterpenes. These results are in agreement with reeent reports by Rajesh et al (2003)
showing that pretreatment of glioma eells with POH sensitized the cells to irradiation.
These authors further coneluded that the mechanism o f action included enhanced
apoptosis induetion in the treated cells, although they used higher irradiation doses (5Gy)
eompared to the dose used in the present study.
To eonfirm apoptosis induction by the monoterpenes, FITC-Annexin -V/PI
staining flow eytometry was performed with head and neek caneer cells, Jurkat cells
serving as the eontrol eells. In the early stages o f apoptosis one o f the ehanges that occur
at the cell surface involves the translocation o f phosphatidylserine (PS) from the inner
side o f the plasma membrane to the external surfaee o f the cell. Annexin-Y being a Ca
dependent phospholipids binding protein binds to PS with high affinity at the external
surface, hence it is used to measured cells that undergo early apoptosis. We report that
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pretreatment with 1.0 mM PA or 0.5 mM POH increased the cell population o f both
necrotic and apoptotic cells (p.46-49) confirming the observation seen with increased in
apoptotic index in HNSCC cells . For cells that are apoptotic, the plasma membrane
remains intact, but necrotic cells release its content leading to shrinking o f plasma
membrane. Figures 11-17 (p.46-49) shows the results o f applying annexin V assay to
indicate the number o f apoptotic and necrotic cells in relation to time elapsed after 72 hrs
treatment with PA or POH (p.46-49). We confirm that pretreatment o f cells prior to
radiation by monoterpenes results into induction o f apoptosis (Fig. 17 and 18, p.52-53).

5.2 Conclusions and recommendations for further study
In a biological system, when radiation is absorbed, free radicals are produced that
cause the breakage o f the nucleic acids and other macromolecules, causing DNA damage.
Many drugs have been reported to have the properties o f inhibiting the repair o f the DNA
damage in cancer cell caused by radiation exposure (Rosenthal et al., 1998). Our data
indicated that the monoterpenes acted as radiosensitizers through the induction o f cell
death via apoptosis in combination chemo-radiation treatment o f head and neck cancer
cells in vitro. Our data also indicated that the monoterpenes POH as well as its
metabolite PA acted as radiosensitizers in combination chemo-radiation treatment o f head
and neck squamous cell carcinoma in vitro.
As the knowledge o f the molecular events surrounding the cause o f cancer has
advanced, attention has been center on developing novel agents with new mechanisms o f
action. Since this was the first research work to elucidate the radio-sensitization of

56

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

perillic acid in head and neck cancer cells, further studies on the sensitization effect o f the
monoterpenes will help in elucidating the mechanism o f action. This will include
(i)

the effects o f higher radiation doses

(ii)

the effects o f fractionated doses

(iii)

comparative effects o f alternating and concomitant chemo-radiation
protocols

(iv)

the role o f monoterpenes in the expression levels o f p53 and other related
signaling proteins like bcl-2, p21 in downstream o f p53 regulation
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5.3 Definition o f terms
Terms

Definition

Apoptosis

Programmed cell death

Necrosis

Death o f cells through injury, disease or treatment.

HNSCC

Head and neek squamous cell carcinoma

Cell cycle arrest

The halt in a series o f events involving the growth,
replication, and division of a eukaryotic cell

p53

Tumor suppressor protein

Squamous cell carcinoma

Cancerous cells that affect the middle layer o f the skin

Inhibition

The reduction or o f a biochemical reaction, due to
interaction with a chemical agent

Proliferation

Continuous development o f cells

Gy

Gray is the imit o f radiation dose

Go-Phase

Resting period o f cells

Gi-Phase

Growth and preparation o f the chromosomes for
replication

G 2-Phase

Preparation for cell division

M-Phase

Mitosis or cell division

S-Phase

Synthesis o f DNA
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SUMMARY:
Several of the current chemotherapeutic drugs (vinblastine, methotrexate, taxol,
etc) were first identified in plants. In developing countries, the practice o f medicine still
relies heavily on plant and herbal extraets for the treatment o f human ailments. Current
interests in phytochemicals as agents for the treatment o f human cancers were rekindled
because these compounds occur naturally and are less toxic than synthetic agents.
Monoterpenes occur naturally in a wide variety o f plants while the jasmonates are a
family o f plant stress hormones. We studied the effects o f the naturally occurring
monoterpene, perillyl alcohol (POH) and its major human metabolite, perillic acid (PA),
on human head & neck (BroTo and SCC-25), and human lung carcinoma (HTB-182 and
CRL-5928) cell lines. We also studied the effects o f the jasmonates on human prostate
adenocarcinoma (PC-3 and HTB-81) cell lines in culture. Both classes o f compounds
inhibited the proliferation o f cancer cells. POH was more effective than PA at reducing
the proliferation o f human head & neck and lung squamous cell careinoma cells. The
jasmonates also inhibited the proliferation o f prostate cancer cells. Differential potencies
were observed between the various members o f the jasmonate family. The monoterpenes
and the jasmonates should be further investigated for their effeets on human cancer cell
lines.
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INTRODUCTION:
The effects o f several plant compounds on animal cells have been studied. Plant
compounds such as carotenoids, lycopene, indoles, thiocyanates and others exhibit
antioxidant properties in animal cells while the carotenoids and vitamin E also serve as
nutrients. Other plant compounds such as tea polyphenols, indoles and monoterpenes
showed chemopreventive activity in a number o f human cancers (1-3).
Monoterpenes are a diverse class o f isoprenoid compoimds synthesized by plants
through the mevalonate pathway (4). d-Limonene (LIM) and perillyl alcohol (POH) are
naturally occurring monoterpenes commonly found in the essential oils o f citrus fruits,
lavender, spearmint, cherries and others (5,6). Both LIM (7-9) and POH (10) elicited
chemotherapeutic effects against mammary tumors causing the complete regression o f
more than 80% o f established DMBA- or NMU-induced mammary carcinomas. In vivo.
both POH and LIM are readily metabolized to the major metabolites, perillic acid (PA)
and dihydroperillic acid (DHPA), in experimental animals (11). Pre-clinical and
pharmacokinetic studies o f limonene (12,13) and POH in humans (14,15) showed that
human metabolites o f both agents (16) are similar to the metabolic profile observed in
experimental animals (11). Although the mechanism o f the anti-tumor action o f the
monoterpenes is not yet known, several potentially important drug-related activities have
been observed (17-21).
The jasmonates, first isolated from the jasmine plant, are a class o f plant stress
hormones consisting o f cis-jasmone (CJ), jasmonic acid (JA), and methyl jasmonate (MJ)
respectively (22). JA is involved in the intracellular signaling response by plants to injury
while MJ causes the induction o f a proteinase inhibitor, which accumulates in response to

61

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

wounding or pathogenic attacks (23). In plants, this response is termed the
hypersensitive response (HR) and results in the formation of a zone o f dead cells around
the infection site, the synthesis o f salicylic acid and the accumulation o f antimicrobial
agents, such as pathogenesis-related proteins and phytoalexins (24,25). The layers o f
dead cells that surround the site o f pathogen entry are thought to function as a physical
barrier that inhibits further proliferation and spread o f the pathogen.
Available reports indicate that the jasmonates may also have effects on animal
cells in culture. Jasmone and analogs, for example, inhibited the proliferation and
induced cell death in lymphoblastic leukemia (MOLT-4) and breast cancer cells cultured
in vitro, but did not affect normal human blood lymphocytes or erythrocytes (26). JA and
MJ caused apoptotic death, increased caspase-3 activity and induced mitochondrial
membrane depolarization in these cell lines (26).
We postulated that these plant compounds might inhibit the proliferation o f
human cancer cells in vitro. We, therefore, investigated the effects o f the monoterpenes
(POH and PA) on the proliferation o f human squamous cell carcinoma o f the head &
neck (BroTo; SCC-25) and lung (HTB-182; CRL-5928) cell lines. We also studied the
effects o f the jasmonates on prostate adenocarcinoma (PC-3; HTB-81) cell lines cultured
in vitro. The effects o f these agents on human lung fibroblast, normal (HFL-1), cultured
in vitro were also evaluated. In this report, we present preliminary findings showing that
these bioactive plant compounds inhibited the proliferation and induced cell death in
human cancer cells in culture.
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MATERIALS AND METHODS:
Chemicals and Reagents:
The monoterpenes (POH and PA) were obtained from Aldrich Chemical
Company (Milwaukee, WI). The jasmonates (CJ, JA, MJ) were purchased from Sigma
Chemical Company (St. Louis, MO). Cell culture media (RPMI, EMEM, DMEM,
H am ’s F12 and Ham ’s F12-K) were obtained from ATCC (Manassas, VA). Phosphate
buffered saline (PBS, lacking Ca^^ and Mg^^), penicillin (100 units/ml) and streptomycin
(lOOpg/ml) (P/S) were obtained from Invitrogen Corporation (Grand Island, NY). Fetal
bovine serum (FBS) was purchased from HyClone Laboratories (Logan, UT). All other
reagents and chemicals were o f the purest grade and procured from reputable vendors.

Cells and Cell Culture:
Human squamous cell carcinoma o f the tongue (SCC-25), human squamous cell
carcinoma o f the lung (HTB-182 and CRL-5928), human prostate adenocarcinoma (PC-3
and HTB-81) and human lung fibroblast, normal, (HFL-1) cell lines were purchased from
ATCC (Manassas, VA). Human squamous cell carcinoma of the tongue (BroTo) cell line
was a gift from J. Truelson, MD, Department o f Otolaryngology, University o f TexasSouthwestern Medical Center. Cells were cultured in appropriate media supplemented
with 10% FBS and 1% P/S. Cells were dislodged with trypsin-EDTA, adequate amounts,
as specified in each study, were plated and allowed to adhere onto tissue culture plates
overnight. The respective monoterpene (POH, PA) or jasmonates (JA, CJ, MJ) was
dissolved in DMSO to give a I .CM stock solution. Cisplatin was mixed directly with
sufficient medium to achieve the desired concentration. Treatment solutions were
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prepared by diluting the stoek solution with the appropriate medium, with occasional
mixing at 37°C for at least 1 hr, before use. Cells were treated by replacing the growth
medium with medium containing the desired concentration of each agent and incubated at
37°C in humidified, 5% CO 2 atmosphere. Cells in control wells received either medium
only (for cisplatin and 5-FU controls) or medium containing DMSO (<0.3% v/v; for
jasmonate and monoterpene controls). At stated time points, effects o f the agents were
determined as described below.

Cvtotoxicitv Assavs:
Mitochondrial Dehvdrogenase TMTT) Assav:
The effects o f the different agents on cancer cell lines were studied using the
MTT assay (27), an assay based on the reduction o f the yellow dye, 3-(4,5-dimethyl-2thiazol)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to purple formazan crystals by the
mitochondrial dehydrogenase enzyme. Specifically, cells (5,000 cells/well) were plated
in 96-well plates and allowed to adhere overnight. Cells were treated with the agents or
the appropriate Control medium for up to 72 hr. After exposure to the agent for a
specified period o f time, the treatment medium was replaced with lOOpl o f fresh medium
and lOpl o f MTT (5mg/ml) and the plate incubated at 37°C in humidified 5% CO 2
atmosphere for 3 hr The reaction was stopped and the formazan crystals solubilized with
lOOpl of the stop solution (O.IN HCl in isopropanol). The optical density o f the solution
was read at 570nm against a reference at 630nm on an ELISA plate reader (Packard
Instruments, Meridan, CT). Cell viability was calculated as a percentage o f the control
cells ( 100%).
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Colony Formation Assav:
The long-term effects o f the agents on the treated cells in culture were assessed
using the colony formation assay (CFA) as previously described (28). Specifically, cells
(200-500 cells/well) were plated in 6-well plates and allowed to adhere overnight. The
following day, the control or the treatment medium (with the desired concentration o f an
agent) was added to appropriate wells and incubated for the desired time period. Cells
were washed twice with IX PBS and once with the fresh medium. Fresh medium was
then added to each well and the cells were incubated for 10-14 days. The plates were
viewed under the microscope every other day to monitor cell growth. At termination, the
medium from each well was removed by aspiration, the cells washed with IX PBS and
the colonies stained with crystal violet (0.5% in 95% ethanol) for 5 min and the dye was
gently rinsed off. Colonies, each containing at least 50 cells, were counted and the cell
viability or drug effectiveness was assessed based on the number o f colonies formed in
the treatment group relative to the control ( 100%).

Flow cytometry analysis for cell cycle distribution:
The DNA content o f treated cells was assessed by flow cytometry following
propidium iodide (PI) staining as previously described (28). Cancer cells (5 x 10^) were
plated in a 60mm diameter tissue culture plate overnight to adhere. The cells were then
treated with varying concentrations o f POH, PA or MJ for the specified period o f time.
Following treatment, cells were harvested, washed, re-suspended in lOOp.1 o f ice-cold
PBS, fixed with 90% ethanol and kept at 4°C prior to flow analysis. To determine the
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cell cycle distribution and to quantitate apoptotic cells with subdiploid DNA content,
cells were stained with DNA staining solution (100 pg/ml PI, 0.1% Triton X-100, and 1
mg/ml RNase A (DNase-free) in PBS lacking Ca^^, Mg^^; 1:1:1 by volume) and analyzed
using a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). PI fluorescence
was linearly amplified and both the area and width o f the fluorescence pulse were
measured. Twenty thousand events were acquired and the percentages o f hypodiploid
(apoptotic; sub-Go/Gi) events and o f cells in Go/Gi, S and Gi-M phases were determined
using the DNA analysis software ModfitLT version 3.0 (Verity Software, Topsham,
Maine).

Statistical Analvses:
Results were expressed as Mean ± SD o f replicate analyses accompanied by the
number o f independent experiments. Data analyses were performed by one-tailed t-test.
Differences at p<0.05 or better were considered statistically significant.

RESULTS:
Effects o f monotemenes on squamous cell carcinomas:
The effects of the monoterpenes (POH and PA) on the proliferation o f human
head & neck squamous cell carcinoma and human lung fibroblast (HFL-1) cells in culture
were evaluated using MTT and CFA techniques. The concentration o f POH that
inhibited proliferation by 50%

(IC 5 0 )

was calculated (Fig 1) to be 625pM (BroTo),

SOOpM (HFL-1) and 930pM (SCC-25). BroTo cells appeared more sensitive to POH
than SCC-25 and HFL-1 cells. PA was not as effective as POH against the cell lines
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though at concentrations greater than 750pM, PA inhibited proliferation o f SCC-25 cells
by greater than 30% (Fig IB). POH (Fig 1A) was more effective than PA (Fig IB) at
reducing cellular proliferation. We evaluated the long-term effects o f cell exposure to the
monoterpenes using colony formation assay technique. Exposure to POH (500pM or
lOOOpM) for 24 hr significantly (p < 0.05) reduced the proliferation o f SCC-25 and
BroTo cells. HFL-1 cells also appeared very sensitive to POH. Figure 2B shows the
effect o f PA on these cell lines. Similar to earlier observations (Fig IB), SCC-25 cells
appeared more sensitive to PA than either the BroTo or HFL-1 cells. Exposure to
lOOOpM PA inhibited the proliferation o f SCC-25 cells by >25% (Fig 2B).
We also examined the effects o f the monoterpenes on human lung squamous cell
carcinoma cell lines (CRL-5928 and HTB-182). Both POH and PA reduced the
proliferation of CRL-5928 cells in dose- and kinetic-dependent manners (Fig 3). The 72hr IC 50 for POH was 750|xM compared to 1800 pM for PA (Fig 3). Similar responses
were observed with HTB-182 (data not shown). We also compared the effects o f POH
(500pM), PA (lOOOpM), cisplatin (2.5pg/ml) and 5-FU (lOOpg/ml) on the human
squamous cell carcinoma (HTB-182) cell line treated for 24,48 or 72 hr using
mitochondrial dehydrogenase assay technique (Fig 4). We found that at 48 hr, the
monoterpenes reduced cellular proliferation better than in the groups treated with
cisplatin or 5-FU (Fig 4). The relative efficacy o f these agents, at the stated
concentrations and 48 hr exposure, were POH>PA>cisplatin>5-FU (Fig 4). The response
to POH at 72 hr (Fig 4) is not clear.

Effects o f the iasmonates on human prostate cancer cells:
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We also evaluated the effects o f the plant stress hormones on human prostate
adenocarcinoma (PC-3; HTB-81) cell lines cultured in vitro. Figure 5 shows the
comparative effects o f the jasmonates on human adenocarcinoma cell lines treated for 72
hr. The IC 50 values were MJ (1.8mM) and CJ (2.25mM). An IC 50 value was not
achievable for JA (Fig 5A). PC-3 cells exhibited differential sensitivities to the three
jasmonates with MJ being more effective than CJ or JA at reducing the proliferation o f
the cancer cells (Fig 5A). At concentrations greater than 2.0mM, MJ significantly
inhibited proliferation o f PC-3 cells better than CJ (p<0.05) or JA (p<0.005). MJ also
significantly (p< 0.005) inhibited the proliferation o f HTB-81 prostate cancer cells better
than CJ or JA (Fig 5B) at ImM concentration or higher.

Plant compounds induced cell cvcle arrest and sub-Gn/Gi populations in cancer cells:
In preliminary experiments, we studied the effects o f POH, PA and MJ on cell
cycle distribution and subdiploid DNA content o f cancer cells. POH caused cell cycle
arrest in the G q/ G i phase and an increase in the hypodiploid content o f SCC-25 and
BroTo cells (Table 1A) after 24 hr exposure. PA also caused cell cycle arrest in the
Go/Gi phase in BroTo cells but not in SCC-25 cells and slightly increased the sub-Go/Gi
content compared to the control (Table lA ). Table IB shows that MJ (at 2mM) caused
cell cycle arrest at G q/G i phase in both PC-3 and HTB-81 cell lines in a time-dependent
fashion. The cell cycle arrest was accompanied by increased proportion o f sub-Go/Gi
population in both cell lines (Table IB). These preliminary data will be further studied to
confirm the induction o f apoptosis.
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DISCUSSION AND CONCLUSION:
We used biochemical, cytotoxicity and flow cytometric assays to evaluate the
potential effects o f 2 major plant compounds on the proliferation o f several human cancer
cell lines in culture. We found that POH and, to a lesser extent PA, the major circulating
metabolite o f the monoterpenes, reduced the proliferation of human head & neck
squamous cell carcinoma SCC-25 (Fig 1), human lung squamous cell carcinoma cell
lines CRL-5893 (Fig 3) and HTB-182 (Fig 4) in culture. Our data suggest that the
mechanism for the proliferation inhibition by these compounds may involve cell cycle
arrest and the induction o f apoptosis. Ongoing and further investigations will confirm
these effects.
Several reports have indicated that naturally occurring monotepenes (d-limonene
and perillyl alcohol) are present in human diets (13,29,30) though only the metabolites o f
these compounds have been detected in blood plasma following consumption o f the
monoterpenes (12-16). Since the monoterpenes are protective against a number o f
different cancers (7-10,17,20) and are currently being studied in clinical trials (12,14,15),
we postulated that the mechanism o f action o f these compounds would involve the
circulating metabolites. Furthermore, recent reports indicated that PA, at doses (13.5mM) higher than physiologically achievable levels, inhibited the proliferation o f
human colon cancer cells by the up-regulation o f p 21^^^^^'^^ protein and downexpression o f cyclin D1 and cdk4 proteins (31). PA also inhibited the proliferation of
smooth muscle cells via the inhibition o f protein prénylation (32). In cultured rat lens,
however, PA appeared to induce opacification o f the cultured lenses (33) but via a
mechanism other than the inhibition o f isoprenylation. Our results, showing cell cycle
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arrest and the inhibition o f proliferation o f these cancer cells at physiologically
achievable PA concentrations, are in agreement with these reports (30-33).
When we tested the plant stress hormones on human prostate adenocarcinoma cell
lines, we found that MJ was a more potent inhibitor o f the proliferation o f the cancer cells
in culture than CJ or JA. Although CJ showed some activity against PC-3 cell line (Fig
5A), it did not elicit any inhibitory effect on H TB-81 cells at the concentrations tested.
JA was the least effective, not showing any effect on either cell line (Fig 5). These
results are in agreement with the reports by Fingrut and Flescher (26) who tested the
jasmonates on human leukemia (MOLT-4) and breast cancer cell lines. These
investigators found that MJ was a more potent inhibitor o f proliferation o f the cells than
JA. They concluded that the mechanism o f action o f MJ appeared to be via the induction
o f apoptosis (26). Our preliminary flow cytometry data following the propidium iodide
staining and DNA analysis o f cells treated with POH, PA or methyl jasmonate (Table 1)
indicated that the inhibition o f proliferation by these plant compounds and metabolite
might be through cell cycle arrest and the induction o f apoptosis.
The role o f plant compounds on the etiology o f human diseases is currently being
investigated intensively. Evidence show that as humans include more plant products in
their diets, the potential for the consumption o f several plant compounds that may be
protective against human diseases increases. Current efforts to identify, characterize and
understand the mechanism o f action o f these bioactive plant compounds are in the right
direction. Further studies are in progress to delineate the mechanism(s) o f action o f the
monoterpenes and the jasmonates, and to assess their potential effects on human cancer
cells.
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Table 1; Effects o f bioactive plant compounds on cell cycle distribution and hypodiploidy
in head & neck squamous cell carcinoma (1 A) and prostate adenocarcinoma (IB ) cell
lines in vitro.
lA : Effect o f 24 hr exposure to POH and PA on BroTo and SCC-25 cell lines
BroTo
SCC-25
G i- M
subG o /G ,
G 2 -M
Treatment G o / G i
S
S
G o /G i

54.0
±7.1

33.2
± 5 .0

0.5mM
POH

76.5
± 2 .9

12.0

l.OmM
PA

70.7
± 3.1

Control

G o /G i

2.1

0.33
± 0.1

46.1
± 4 .5

38.2
± 2 .7

15.7
± 1.8

0.28
± 0.1

± 2.5

11.5
± 0 .4

2.87
± 1.1

65.7
± 0 .5

23.9
± 0 .9

10.5
± 0 .3

9.55
± 0.2

18.5
± 4 .7

10.8

1.36
± 0.1

45.4
± 0 .5

41.7
± 0.8

12.8

±

± 0 .5

0.54
± 0.1

12.8

±

1.6

IB: Effect of methyl jasmonate (MJ) on PC-3 and HTB-81 cells in culture
HTB-81
PC-3
G 2 -M
G o /G i
S
G 2 -M
Treatment G o / G i
S
subControl
2.0mM
MJ
Control
48 hr
2.0mM
MJ

subG o /G ,

G o /G i

24 hr

sub-

0.1

53.8
± 0 .5
40.6
± 3 .0

30.0
± 0.6
32.9
± 0 .3

16.2
± 1.1
26.5
± 2 .7

± 0 .7

0.15
± 0.0
1.63
± 2.0

81.0
± 1.4
51.8
± 6 .9

9.9
± 0 .5
20.7
± 0.6

9.1
± 0 .9
27.5
± 6.2

0.15
± 0.0
4.0
± 1.0

51.9
± 0 .3
46.3
± 0 .4

27.0
± 0.4
30.8
± 0.1

21.2

0.11

± 0 .7
22.9
± 0 .3

±
±

53.8
± 1.5
73.0
± 1.0

26.9
± 1.6
5.5
± 1.8

19.3
± 0.1
21.5
± 0.8

0.0

0.12

Control

0.33
± 0 .3
1.02

13.2
16.2
0.14
5.6
0.18
70.7
87.8
6.6
72 hr
± 0.6
± 0 .3
± 0.6 ± 0.8
± 0.1
± 0 .5
± 0.1
± 0.0
2.0mM
48.2
28.2
23.7
48.1
31.3
20.6
0.3
8.8
MJ
± 0.3
± 0.1
± 0.2
± 0.2
± 4.2
± 6.3
± 2.1
± 3 .4
Cancer cells ( 5 x 1 0 ) were plated in 60mm diameter tissue culture plates and treated with
POH, PA or MJ for the specified period o f time and analyzed on a FACSCalibur flow
cytometer as described in the text. Values are M ean ± SD of triplicate analyses.
Sub-Go/Gi = % Apoptosis or hypodiploid population
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FIGURE LEGENDS:

Figure 1: Effect o f the monoterpenes on human head and neck cancer (SCC-25; BroTo)
and human lung fibroblast (HFL-1) cells in culture. Cells were exposed to varying
concentrations o f perillyl alcohol (POH) or perillic acid (PA) for 24 hr and the effects
assessed by mitochondrial dehydrogenase assay as described in the Methods section.
Cytotoxicity was measured as cell viability. Cell viability was calculated as a percentage
o f untreated Control cells (100%). Figure represents a plot o f the log value o f % viability
versus concentration o f monoterpene. Values are Mean ± SD (n= 6); result is
representative o f 3 separate experiments.

Figure 2 : Monoterpenes caused long-term inhibition o f proliferation o f cells in culture.
Human cancer (SCC-25; BroTo) or human fibroblast (HFL-1) cells were exposed to
equimolar concentrations o f perillyl alcohol (POH) or perillic acid (PA) for 24 hr and the
effects determined by colony formation assay as described in the Methods section. The
colonies (containing >50 cells/colony) formed were counted and the cell viability was
calculated as a percentage o f the untreated Control groups (100%).

Figure 3: Cytotoxic effects o f monoterpenes on human lung cancer cell line CRL 5928.
Cells were exposed to varying concentrations o f perillyl alcohol (POH) or perillic acid
(PA) for 24, 48 or 72 hr and the effect evaluated as described for Figure 1.
Figure 4 : Sensitivity o f lung squamous cell carcinoma cells to different chemotherapeutic
agents. Human lung cancer (HTB-182) cells were exposed to perillyl alcohol (POH),
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perillic acid (PA), cisplatin or 5-fluorouracil (5-FU) for 24,48 or 72 hr and the viability
determined using the MTT assay technique as described for Figure 1.

Figure 5: Comparative effects o f the jasmonates on human prostate cancer cells in
culture. Human prostate adenocarcinoma cell lines PC-3 or HTB-81 were treated with
varying concentrations o f jasmonic acid (JA), cis-jasmone (CJ) or methyl jasmonate (MJ)
for 72 hr and the cytotoxicity determined as described for Figure 1.
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Figure 1: Effects o f monoterpenes on human head & neck cancer and
fibroblast cells in culture
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Figure 2: M onoterpenes caused long-term inhibition o f
proliferation o f cancer cells in culture
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Figure 3: Monoterpenes exhibited cytotoxic effects against human lung cancer
(CRL 5928) cells in culture
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Figure 4: S ensitivity o f lung squam ous c e ll carcinom a (H T B 182) cells to different chem otherapeutic agents
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72

Figure 5: Comparative effects o f the jasm onates (JA, CJ, MJ) on
cultured human prostate cancer (PC-3; H T B -81) cells

too
PC-3

JA
CJ
MJ

U
q -i

o

10
1

0
03

2

3

100

• 1— (

I

HTB-81

JA

MJ

0

2

1

3

Concentration, mM

82

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

REFERENCES
1. Al-Sarraf M. “Head and neck cancer: Chemotherapy concept.” Sermin Oncol.
15(1988): 70-85.
2. American Cancer Society, Cancer Facts & Figures 2004, American Cancer Society,
Inc., Atlanta, GA, 2004.
3. Alonso, W. R., Rajaonarivony, J. I. M., Gershenzon, J. and Croteau, R. “Purification o f
4S-limonene synthase, a monoterpene cyclase from the glandular trichomes of
peppermint {Menthapiperita) and spearmint {Mentha spicata).” J. Biol. Chem.
267(1992): 7582-7587.
4. Austin, C. A., Shephard, E. A., Pike, S. F., Rabin, B. R. and Philips, I. R. “The effect o f
terpenoid compounds on cytochrome P-450 levels in rat liver.” Biochem. Pharmacol.
37(1988): 2223-2229.
5. Brown, D., Wang, R. and Russel, P. “Antiepidermal growth factor receptor antibodies
augment cytotoxicity o f chemotherapeutic agents on squamous cell carcinoma cell
lines.” Otolaryn. Head and Neck Sur. 122(2000): 71-83.
6.

Bums, J. E., Baird, M. C., Clark, L. J., Bums, P. A., Edington, K., Chapman, C.,
Mitchell, R., Robertson, G., Soutar, D. and Parkinson, E. K. “Gene mutations and
increased levels o f p53 protein in human squamous cell carcinomas and their cell
lines.” B rJ Cancer. 6(1993): 1274-84.

83

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

7. Chayet, L., Rojas, C., Cardemil, E., Jabalquinto, A. M., Vienna, R. and Cori, O.
“Biosynthesis o f monoterpene hydrocarbons from (1-3H) neryl pyrophosphate and (13H) geranyl pyrophosphate by soluble enzymes from citrus limonum.” Arch. Biochem.
Biophys. 180(1977): 318-327
8.

Chow, S. H., Salazar, D. and Hakim, A. I. “Pharmacokinetics o f perillic acid in humans
after a single dose administration o f citrus preparation rich in d-limonene content.”
Cancer Epidem. Biom. Prev. 11(2002): 1472-1476.

9. Clark, S. “Protein isoprenylation and méthylation at carboxyl-terminal cystein
residues.” Annu. Rev. Biochem. 61(1992): 355-386.
10. Clark, S. S., Perman, S. M., Sahin, M. B., Jenkins, G. J. and Elegbede, J. A.
“Antileukemia activity o f perillyl alcohol (POH): uncoupling apoptosis from G q/G i
arrest suggests that the primary effect o f POH on Bcr/Abl-transformed cells is to induce
growth arrest.” Leukemia 16(2002): 213-222.
11. Crowell, P. L. and Gould, M. N. “Chemoprevention o f mammary cancer by
monoterpenoids.” Crit. Rev. Oncogenesis 5(1994a): 1-22.
12. Crowell P. L., Elson, C. E., Bailey, H. H., Elegbede, J. A., Haag, J.D. and Gould, M. N.
“Human metabolism o f the experimental cancer therapeutic agent d-limonene.” Cancer
Chemother. Pharmacol. 35(1994b): 31-37.
13. Crowell, P. L., Lin, S., Vedejs, E., and Gould, M. N, “Identification o f metabolites of
the antitumor agent d-limonene capable o f inhibiting protein isoprenylation and cell
growth”. Cancer Chemother. Pharmacol. 31(1992): 205-212.

84

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

14. Elegebede, J. A., and Gould, M. N. “Monoterpenes reduced adduets formation in rats
exposed to aflatoxin B ,.” Afr. J. Bioteehnol. 1(2002): 46-49.
15. Elegbede, J. A., Elson, C. E., Tanner, M. A., Qureshi, A., and Gould, M. N. “Inhibition
o f DMB A-indueed mammary cancer by the monoterpene d-limonene.” Carcinogenesis,
5(1984): 661-664.
16. Elegbede, J. A., Elson, C. E., Tanner, M. A., Qureshi, A. and Gould, M. N. “Regression
o f rat mammary tumors following dietary D-limonene.” J. Natl. Cancer Inst., 76(1986):
323-325.
17. Elegehede, J. A., Flores, R. and Wang, C. R. “Perillyl alcohol and perillyladehyde
induced cell cycle arrest and cell death in BroTo and A549 cells cultured in vitro.” Life
Science 73(2003): 2831-2840.
18. Elegbede, J. A., Maltzman, T. H., Elson, C. E. and Gould, M. N. “Effects o f
anticarcinogenie monoterpenes on phase II hepatic metaholizing enzymes.”
Carcinogenesis 14(1993): 1221-1223.
19. Fields, R. D. and Lancaster, M. V. “Dual attribute continuous monitoring o f cell
proliferation/cytotoxicity.” American Biotechnology Laboratory 11(1993): 48-50.
20. Ferri, N., Amaboldi, L., Orlandi, A., Yokoyama, K., Gree, R., Granata, A., Haehem,
A., Paoletti, R., Gelb, H. M. and Corsini, A. “Effect o f S(-) perillic acid on protein
prénylation and arterial smooth muscle cell proliferation.” Biochem. Pharmacol.
62(2001): 1637-1645.
21. Goldstein, J. L. and Brown, M. S. “Regulation o f the mevalonate pathway.” Nature
343(1990): 425-430.

85

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

22. Gordon, S. G. Basic Clin. Radiobiology. In: Models o f radiation cell killing (Michael,
C. Joiner Eds.) London, Edward Arnold Publishers, (1993): 143-150
23. Haag, J. D. and Gould, M. N. “Mammary carcinoma regression induced by perillyl
alcohol, a hydroxylated analog o f limonene.” Cancer Chemother. Pharmacol. 34(1994):
477-483.
24. Haag, J. D., Lindstrom, M. J. and Gould, M. N. “Limonene-induced regression o f
mammary carcinomas.” Cancer Res., 52(1992): 4021-4026.
25. Hakim, I. A., Harris, R. B. and Ritenbaugh, C. “Citrus peel use is associated with
reduced risk o f squamous cell carcinoma o f the skin.” Nutr. Cancer 37(2000): 161-168.
26. He, L., Mo, H., Hadisusilo, S., Quereshi, A. A. and Elson, C. E. “Isoprenoids suppress
the growth o f murine B16 melanomas in vitro and in vivo.” J. Nutri. 127(1997):

668-

74.
27. Jia, L., Macey, G. M., Yin, Y., Newland, C. N. and Kelsey, M. S. “Subcellular
distribution and redistribution o f Bcl-2 family proteins in human Leukemia cells
undergoing apoptosis.” Blood 93(1999): 2353-2359.
28. Jirtle, R. L., Haag, J. D., Ariazi, E. and Gould, M. N. “Increased mannosc 6phosphate/insulin-like growth factor II receptor and transforming growth factor pi
levels during monoterpene-indueed regression o f mammary tumors. Cancer Res.
53(1993): 3849-3853
29. Kawata, S., Hagase, T., Yamasaki, E., Ishiguro, H., Matsuzawa, Y. “Modulation o f the
mevalonate pathway and cell growth by pravastatin and cf-limonene in a human
hepatoma cell line (Hep G2).” Br. J. Cancer. 69 (1994): 1015-1020

86

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

30. Kelloff, G. J., Boone, C. W., Crowell, J. A., Steele, V. E., Lubet, R. A., Doddy, L. A.,
Malone, W. P., Hawk, E. T. and Sigman, C. C. “New agents for cancer
ehemoprevention.” J. Cellular Biochem. 268 (1996): 1-28.
31. Kies, M. S., Haraf, D. J., Rosen, F. H., Stenson, K., List, M., Brockstein, B., Chung, T.,
Mittal, B. B., Pelzer, H., Portugal, L., Rademaker, A., Weichselbaum, R and Yokes, E.
E. “Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and
hyperfraetionated radiation for locally advanced squamous head and neck cancer.” J.
Clin. Oncol. 19(2001): 1961-1969.
32. Kim, E. H., Krug, A. M., Han, I., Ensley, J., Yoo, H. G., Forman, D. J. and Kim, C. H.
“Neutron Radiation Enhances Cisplatin Cytotoxicity Independently o f Apoptosis in
Human Head and Neck Carcinoma Cells.” Clin. Cancer Res. 6(2000):4142-4147.
33. Kjonaas, R. and Croteau, R. “Demonstration that limonene is the first cyclic
intermediate in the biosynthesis o f oxygenated p-menthane monoterpenes in Mentha
piperita and other Mentha species." Arch. Biochem. Biophys. 220(1983): 79-89.
34. Landis, S., Murray, T., Bolden, S. and Wingo, P. “Cancer Statistics.” CA Cancer J.
Clin. 58(1998): 6-29.
35. Lange, B. M., Ketchum, E. B. R. and Croteau, B. R. “Isoprenoid biosynthesis,
metabolite profiling o f peppermint oil gland secretory cells and application to herbicide
target analysis.” Plant Physiol, 127(2001):305-314.
36. Maltzman, T. H., Christou, M., Gould, M. N. and Jeffcoat, C. R. “Effects o f
monoterpenoids on in vivo DMBA-DNA adduet formation and on Phase I hepatic
metabolizing enzymes.” Carcinogenesis. 12(1991): 2081-2087.

87

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

37. McGarvey, D. J. and Croteau, R. “Terpenoid metabolism.” Plant Cell 7(1995): 10151026.
38. Mills, J. J., Chari, R. S., Boyer, I. J., Gould, M. N. and Jirtle, R. L. “Induction of
apoptosis in liver tumors by the monoterpene perillyl aleohol.” Cancer Res. 55(1995):
979-983.
39. Min, B. M., Back, J. H., Shin, K. H., Gujuluva, C. N., Cherrick, H. M., Park, N. H.
“Inactivation o f the p53 gene by either mutation or HPV infection is extremely
frequent in human oral squamous cell carcinoma cell lines.” Eur J Cancer B Oral
Oncol. 5(1994): 338-45.
40. Murren, R. J., Pizzomo, G., DiStasio, S. A., McKeon, A., Peccerillo, K., Gollerkari, A.,
McMurray, W., Burtness, B. A., Rutherford, T., Li, X., Ho, P. T. and Sartorelli, A.
“Phase I clinical study o f perillyl aleohol in patients with refractory malignancies.”
Cancer Biol. & Therapy 1(2002): 130-135.
41. Rajesh, D. and Howard, P. S. “Perillyl alcohol mediated radiosensitization via
augmentation o f the Fas pathway in the prostate cancer cells.” The Prostate 57(2003):
14-23.
42. Rajesh, D., Stenzel, A. R. and Howard, P. S. “Perillyl alcohol as a
radio/chemosensitizer in maglinant glioma.” J. Biol. Chem. 278(2003): 35968-35978.
43. Reddy, B. S., Wang, C. X., Samaha, H., Lubet, R., Steele, V. E., Kelloff, G. J., Rao, C.
V. “Chemoprevention o f colon carcinogenesis by dietary perillyl alcohol.” Cancer Res
57(1997): 420-425

88

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

44. Ripple, G. H., Gould, M. N., Arzoomanian, R. Z., Alberti, D., Feierabend, G., Simon,
K., Binger, K., Tutsch, K. D., Pomplun, M., Wahamaki, A., Mamocha, R., Wilding, G.
and Bailey, H. H. “Phase I clinieal and pharmacokinetic study o f perillyl alcohol
administered four times a day.” Clin. Cancer Res. 6(2000): 390-396.
45. Ripple, G. H., Gould, M. N., Stewart, J. A., Tutsch, K. D., Arzoomanian, R. Z., Alherti,
D., Feierabend, C., Pomplun, M., Wilding, G. and Bailey, H. H. “Phase I clinieal trial
of perillyl alcohol administered daily.” Clin Cancer Res. 4(1998): 1159-1164.
46. Rotman. M., Aziz, H., Schwartz, D., Cirrone, J., Schulsinger, A., Choi, K. and
Macchia, R. J: “Continuous infusion chemotherapy and irradiation in the treatment o f
advanced bladder carcinoma. In: Chapter 19: Principles and Practice o f Radiation
Oncology (Carlos A. Perez, Luther W. BradyL, eds). New York, Lippincott-Raven Pbl.
(1998): 470-475.
47. Servomaa, K., Kiuru, A., Grenman, R., Pekkola-Heino, K., Pulkkinen, J. O., Rytomaa,
T. “p53 mutations associated with increased sensitivity to ionizing radiation in human
head and neck cancer cell lines.” Cell Prolif. 5(1996): 219-30.
48. Shi, W. and Gould, M. N. “Induction o f differentiation in neuro-2A cells by the
monoterpene perillyl alcohol.” Cancer Lett. 95(1995): 1-6.
49. Shi, W. and Gould M. N. “The anticancer monoterpene perillyl alcohol causes a
decrease in cellular cyelin D1 levels contributing to an early G1 arrest in mammary
cells.” Proc Am Assoc Cancer Res. 38(1997): 263.
50. Stayrook, K. R., MeKinzie, J. H., Burke, Y. D., Burke, Y. A. and Crowell P. L.
“Induction o f the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic

89

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ductal adenocarcinoma relative to untransformed ductal epithelial cells.”
Carcinogenesis 18(1997): 1655-1658.
51. Stupp, R. and Yokes, E. E. “Chemotherapy o f head and neck tumors. IN:
Comprehensive Management o f Head and Neck Tumors.” Yol 1, 2nd Edition. W.B.
Saunders Company, (1987): 141-52.
52. Yanhoefer, U., Rougier, P., Wilke, H., Ducreux, M. P., Lacave, A. J., Yan Cutsem, E.,
Planker, M., Santos, J. G., Piedbois, P., Paillot, B., Bodenstein, H., Schmoll, H. J.,
Bleiberg, H., Nordlinger, B., Couvreur, M. L., Baron, B. and Wils, J. A. “Final
randomized phase II trial o f sequential high-dose methotrexate, fluorouracil, and
doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional
fluorouracil and cisplatin in advanced gastric cancer: a trial o f the European
Organization for Research and Treatment o f Cancer Gastrointestinal Tract Cancer
Cooperative Group.” J. Clin. Oncol. 18(2000): 2648-2657.
53. Yokes, E. E., Kies, S. M., Haraf, J. D., Stenson, K., List, M. A., Humerickhouse, M.,
Dolan, E. M., Pelzer, H., Sulzen, L., Witt, E. M., Hsieh, C. Y., Mittal, B. B and
Weichselbaum, R. R “Concomitant chemoradiotherapy as primary therapy for
locoregionally advanced head and neck cancer.” J. Clin. Oncol. 18(2000): 1652-1661.
54. Yokes, E. E., Stenson, K., Rosen, F. R., Kies, M. S., Rademaker, A. W., Witt, M. E.,
Brockstein, B. E., List, M. A., Fung, B. B., Portugal, L., Mittal, B. B., Pelzer, H.,
Weichselbaum, R. R. and Haraf, D. J. “Weekly earboplatin and paclitaxel followed by
concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and
organ-preserving therapy for advanced head and neck.” J. Clin. Oncol. 21(2003): 320326.

90

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

55. Wattenberg, L. W. “Inhibition o f neoplasia by minor dietary constituents.” Cancer Res.
43(1983): 2448s-2453s.
56. Wattenberg, L. W. “Chemoprevention o f cancer.” Cancer Res. 45(1985): 1-8.

91

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

VITA

Graduate College
University o f Nevada, Las Vegas
Daniel Samaila
Local Address
4201 Claymont Street, Apt. #1
Las Vegas, Nevada 89119
Home Address
2429D Cylbum Avenue,
Baltimore, MD 21215.
Degrees:
Bachelor o f Science, Biochemistry, 1994
University o f Maiduguri, Nigeria
Post Graduate Diploma, Management, 2000
Bayero University Kano, Nigeria
Special Honors and Awards:
Certificate for Graduate TA Excellence in Teaching Award, 2004
University o f Nevada, Las Vegas
American National Dean’s List 2003-2004
Publications:
Samaila, D., Ezekwudo, D.E., Yimam, K.K. and Elegbede, J.A. (2004). BIO ACTIVE
PLANT COMPOUNDS INHIBITED THE PROLIFERATION AND INDUCED
APOPTOSIS IN HUMAN CANCER CELL LINES, IN VITRO. TIBETS 1:34-42.
Samaila, D., Toy, J. B., Wang, C. R. and Elegbede, J. A. (2004). Monoterpenes
Enhanced the Sensitivity o f Head and Neck Cancer Cells to Radiation Treatment In
Vitro. Anticancer Research 24.
Thesis Title: Perillyl alcohol and perillic acid in combination with irradiation affects
cell cycle in HNSCC in vitro.

92

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Thesis Examination Committee;
Chairperson, Dr. J. Abiodun Elegbede, Ph. D.
Committee member. Dr. Bryan Spangelo, Ph. D.
Committee member. Dr. Ronald Gary, Ph. D.
Graduate Faculty Representative, Dr. Susan Meacham, Ph. D.

93

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

